Malaysia: +603 2779 0098
NASH continues to be a huge unmet clinical need globally, and although no therapy has received regulatory approval, there continues to be research advancing our understanding of the disease’s mechanisms. Developments in non-invasive diagnostic biomarkers continue to offer the hope that they will replace liver biopsies and there have been improvements to in vivo liver models. All these are the focus of this year’s congress as well as new preclinical and clinical research. The most promising therapeutics in development and business case studies will also be featured at this meeting.
7 hours of networking time
30+ KOLs
Clinical readouts from late stage trials
Investigate how non-invasive tests may replace liver biopsy as the referent standard for the pragmatic clinical management of NAFLD
Learn how semaglutide and combination therapies can address the metabolic drivers of NASH and Explore advances in anti-obesity medications and research into the efficacy of exercise.
Attracting over 200 people the congress is designed to create a collaborative environment in which you can engage with the speakers, sponsors, and other delegations in attendance
International Medical Vice President, NASH & Liver Diseases, Novo Nordisk, Denmark
Professor of Endocrinology & Metabolism, University of Southampton, UK
Senior Researcher, Biomedical Research Institute of Murcia (IMIB), Spain
Professor, German Cancer Research Center (DKFZ), Heidelberg and Director, The M3 Research Institute, Tuebingen, Germany
Director, UNC Liver Center, University of North Carolina, USA
Professor, Fondazione Policlinico Gemelli IRCCS, Catholic University of Rome, Italy
Associate Professor, University of Southern Denmark, Denmark
CSO, Ochre-Bio, UK
Professor in Clinical Biochemistry, University of Westminster
Clinical Director for Gastroenterology & Hepatology, Queen Alexandra Hospital, UK
Senior Research Fellow, University of Oxford, UK
Postdoctoral Researcher, Ghent University, Belgium
Vice President, Pharma, Echosens, France
Executive Director, Cardiovascular Safety Research Consortium, USA
Chief Medical Officer, Altimmune, USA
Director Global Regulatory Affairs, AstraZeneca
Fatty Liver Program Director, Liver Center Research Director, Penn State Health - Milton S. Hershey Medical Center, USA
Chief Medical Officer, Inventiva
Executive Director of Clinical and Preclinical Pharmacology, Galectin Therapeutics, USA
Professor, Karolinska Institutet, Bosch Institute of Clinical Pharmacology, Sweden
Distinguished Scientist, MSD
Assistant Professor, Boston University, USA
Vice-President, Liver Health Programs, Global Liver Institute, USA
Executive Director, Advanz Pharma
Chief Medical Officer, Hepion Pharmaceuticals, USA
Postdoctoral Scientist, The Roger WiIliams Institute of Hepatology, UK
Clinical Research Fellow, University of Oxford, UK
Chief Medical Officer, SomaLogic, USA
Associate Professor, Faculty of Medicine and Health Sciences, Ghent University, Belgium
Merinoff Endowed Chair and Professor of Medicine, The Feinstein Institutes for Medical Research (Northwell Health) and Cold Spring Harbor Laboratory
Associate Professor & Head of Research, Institute of Clinical Chemistry, Inselspital, Bern University Hospital, Switzerland
Senior Corporate Clinical Program Leader, Boehringer Ingelheim
Venture Partner, Apollo Health Ventures, USA
Chief Medical Officer, President of Research & Development, Madrigal Pharmaceuticals
Scientific Officer, Julius Clinical
Clinical Research Fellow and PhD Student, Oxford University & Queen Mary University of London
CEO, CureDiab Metabolic Research GmbH
Senior AI Lead, Tribun Health
VP, Liver Disovery, Insphero
Chief Development Officer, Terns Pharmaceuticals, USA
Sidney Barritt IV, MD, MSCR, is a tenured associate professor and the Director of Hepatology in the UNC liver center at the University of North Carolina. He is also the transplant hepatology fellowship program director. Dr. Barritt conducts clinical outcomes research in nonalcoholic fatty liver disease (NAFLD), general hepatology, and liver transplantation. Dr. Barritt leads the UNC Liver Centers clinical trial program in NAFLD where he is PI on multiple phase 2 and 3 industry sponsored clinical trials and is also a member of the NIH sponsored Drug Induced Liver Injury Network. Dr. Barritt is a collaborator and advisor to multiple other investigators in the allied schools of health, including the Gillings School of Global Public Health, the Eshelman School of Pharmacy and the UNC Adams School of Dentistry. Outside of work, Dr. Barritt enjoys spending time with his family, road running, and triathlons.
Quin is a medical doctor with further degrees in genetics, mathematics, computational biology, and a doctorate in systems genomics. Quin started his first drug discovery liver genomics company over 15 years ago, with the emergence of functional genomics. Over the years he has held numerous leadership positions, from co-steering Oxford Universitys single-cell genomics consortium to founding and leading Novo Nordisks Cellular and Systems Genomics Department. Frustrated by the rising costs of healthcare in an ageing population, and the lack of therapeutic innovation in chronic liver diseases (a top 10 global cause of death), Quin decided to co-found Ochre with a focus on better human data from discovery through to the clinic.
Vinood B. Patel, BSc, PhD, FRSC is currently a Professor in Clinical Biochemistry at the University of Westminster. He presently directs studies on metabolic pathways involved in liver disease, particularly related to mitochondrial energy regulation and cell death. Research is being undertaken to study the role of nutrients, antioxidants, phytochemicals, iron, alcohol and fatty acids in the pathophysiology of liver disease. Other areas of interest are identifying new biomarkers that can be used for the diagnosis and prognosis of liver disease. Professor Patel graduated from the University of Portsmouth with a degree in Pharmacology, completed his PhD in protein metabolism from Kings College Hospital, London and postdoctoral work at Wake Forest University Baptist Medical School. He has edited several biomedical books in including Biomarkers in Toxicology, Molecular Aspects of Alcohol & Nutrition. In 2014, he was elected as a Fellow to The Royal Society of Chemistry.
I am a dietitian with research interests in testing interventions for the management and treatment of obesity-related diseases. Following my dietetic training, I completed a PhD in Nutrition, Dietetics, and Behavioural Sciences piloting a healthy eating and physical activity as a means to improve disease management. As a postdoctoral fellow, I have managed and published multiple randomised trials of behaviour change interventions. I am currently building a programme of work on weight loss in non-alcoholic fatty liver disease, including systematic reviews, epidemiological analyses, and clinical trials. This work is funded by the NIHR Oxford Biomedical Research Centre at the University of Oxford.
Romain Baujard is global lead of Pharma business unit at Echosens, a high-growth medtech company providing comprehensive solutions for chronic liver diseases diagnostics and management. Echosens ambition is to become the diagnostic partner of choice of Pharmas and CROs for drug development and market development. Romain is leading Echosens teams in charge of Echosens clinical partnerships, pharma trial solutions and market development collaborations with our pharmaceutical, biotech and CRO partners. At Echosens we are shaping the future of liver health.
Dr. Seltzer is Executive Director of the Cardiac Safety Research Consortium, an FDA public-private partnership. He has worked with multi-stakeholder groups to define and publish best practices for Adjudication and Data Monitoring Committees. Additionally, he continues to serve on multiple Data Monitoring Committees. Previously he was founder and CEO of ACI Clinical, a WCG Clinical company.
Scott has served as Chief Medical Officer of Altimmune since 2019. He has 20 years of experience of development in gastroenterology, hepatology and metabolism therapeutics. He co-founded Lyric Pharmaceuticals in 2015, where he served as Chief Medical Officer. Dr. Harris also served as Chief Medical Officer of Avaxia Biologics and Ocera Therapeutics, and he headed clinical development at Napo Pharmaceuticals, where he authored the ADVENT study, the first Phase 2/3 adaptive trial to result in a drug approval (Mytesi®, 2012). Dr. Harris has an MD from Harvard Medical School. He completed medical residencies at John Hopkins Hospital and the University of Pennsylvania and a Gastroenterology and Hepatology Fellowship at Yale University School of Medicine. He serves on the scientific advisory board of Protagonist Therapeutics and RedHill Biopharmaceuticals and holds a seat on the faculty of Georgetown University School of Medicine, where he teaches a graduate course in drug development.
Dr. Jonathan Stine is an internationally recognized liver expert with a research and clinical focus on nonalcoholic fatty liver disease and exercise. He has authored more than 70 peer-reviewed papers, including multinational consensus guidelines, and several book chapters. Stine is the recipient of multiple research grants and awards from the American Association for the Study of Liver Diseases, American Cancer Society and National Institutes of Health. He has been a study investigator on more than 20 nonalcoholic fatty liver disease clinical trials and is on the editorial board for several leading hepatology journals. In addition to his scholarly work, Stine is research director for Penn State Health Liver Center. He is also a core faculty member of The ONE Group (Oncology – Nutrition – Exercise).
Dr. Michael P. Cooreman is a gastroenterologist-hepatologist and Chief Medical Officer at Inventiva; before joining Inventiva in 2020 he was Vice President and Global Therapeutic Area Head Gastroenterology and Hepatology at Ferring. He has held R&D leadership roles at Novartis, Merck, Mitsubishi-Tanabe and biotechnology companies, in R&D related to liver and gastrointestinal diseases, immunology, fibrosis, viral diseases and oncology. Before joining R&D in the biopharmaceutical industry, he worked as a staff hepatologist at the Academic Medical Center of the University of Amsterdam.
Dr Radha Krishnan is the Executive director and clinical pathology lead, at Merck Sharpe and Dohme, London, UK. Dr. Krishnan specialises in surgical pathology specifically in the neoadjuvant/adjuvant space, immune-oncology, specifically PD-L1, biomarker assay validations. Within the context of the changing healthcare landscape at the intersection of data sciences and technology, Dr Krishnan is actively involved in efforts to leverage informatics, machine learning and AI methodologies in precision medicine across therapeutic areas of oncology, immunology (IBD) and MASH. For more than a decade before transitioning to industry, Dr Krishnan was the Chief Pathologist at one of the largest Clinical research organisations supporting clinical trials where she was leading anatomic pathology services, biomarker assay development and companion diagnostics.
Jeff McIntyre is the Global Liver Institutes (GLI) NASH Program Director. With over 20 years of public health and advocacy experience, Jeff has worked with leading public health member associations, national physical activity and nutrition campaigns, as well as international obesity organizations to improve public health and chronic disease outcomes. Through specializations in childhood obesity, nutrition, and physical activity, Jeff is GLI’s key point person for coordinating and growing GLI’s NASH initiatives through the NASH Council, International NASH Day, and Beyond the Biopsy campaign.
Aldo Trylesinski MD’s current activities focus on the strategic set-up and implementation of clinical development plans and pre-launch medical activities for new therapies in MASH & liver fibrosis. Previously, Aldo worked at Novartis headquarters as Senior Global Medical Director in various disease areas (Hepatitis, Transplant, Cell/Gene Therapies and Oncology). Aldo was Medical Director at Gilead for over 8 years and Roche for 5 years. Aldo completed his training in Hepato-Gastroenterology in France. He is board qualified in Internal Medicine and Infectious Diseases at the French College of Physicians. Aldo also completed a postdoc in Nutrition and Metabolism and another in Antivirals at the Sorbonne Université of Paris. Aldo worked as consultant physician in several clinical departments and, lastly, in the Immunology Department at the Georges Pompidou European Hospital in Paris until 2009. Aldo has contributed to >65 clinical trials and has >90 publications. In addition, he has been a member of the drug discovery spinoff board of the University of Jerusalem for 4 years. He joined EASL in 1987.
I completed medical studies in Bologna, Italy in 2012 and started clinical training in Nutrition and Metabolism the following year in Milan. Currently working as Clinical Fellow at Oxford Centre for Diabetes, Endocrinology and Metabolism. I have conducted a few studies regarding diabetes, NAFLD, malnutrition and the role of diabetes in Parkinsons disease. I have published 4 articles in peer review journals, and I presented several abstracts to national and international conferences (lates ADA 2022, New Orleans, USA). Research interests: Role of HbA1c reduction in the management and resolution of NAFLD in people living with T2DM, Role of diabetes and diabetes treatment in Parkinsons disease, Non-invasive markers for the screening of HCC in subjects with NAFLD, Use of insulin pumps and hybrid closed loop systems to in the management of T1DM. Prior to SomaLogic, Dr. Williams co-founded the pharma consultancy Decisionability, LLC and authored the book Decisionability: The skill to make your decisions productive, practical and painless. Previously, he worked at Pfizer, Inc., initially in experimental medicine and later as the Vice President and Worldwide Head of Clinical Technology. He was also on the National Advisory Council for Biomedical Imaging and Bioengineering at the U.S. National Institutes of Health. He helped launch the Alzheimers Disease Neuroimaging (ADNI) study and form the FDA-FNIH-PhRMA biomarker consortium. He led or co- led the PhRMA position papers on proof of concept, surrogate endpoints and evidentiary standards for biomarkers and diagnostics. Dr. Williams has degrees in physiology, medicine and surgery, and received his doctorate in medicine and physiology from Charing Cross and Westminster Medical School (now a part of Imperial College, London). He also obtained training in diagnostic imaging at the University of Newcastle Upon Tyne.
Stephen Williams, M.D., Ph.D. is the Chief Medical Officer at SomaLogic and is responsible for Clinical R&D, Medical Affairs and Regulatory and Quality. He oversees clinical application of the SomaScan Platform and has also had roles in launching the life sciences commercial business, assay development and bioinformatics.
Anja Geerts is Professor at the University of Ghent and Head of clinic at the department of Gastroenterology and Hepatology of the University Hospital Ghent in Belgium. Her main interest, both clinical and scientific, is in the field of NAFLD. She is involved in the daily management of NAFLD patients, for which she recently launched a dedicated NAFLD outpatient clinic in the Ghent University Hospital. Many phase 2 and 3 clinical trials about NASH are running in her department. Since 2007 she is the laboratory director of the Hepatology Research Unit. The research work focuses on angiogenesis, endothelial dysfunction and exploration of pathophysiological mechanisms in multiple animal models of liver disease with particularly strong interest in NAFLD. This research work has resulted in multiple publications in highly regarded international journals. Dr. Mishras research is in TGF-? signaling and cancer stem cells in liver and gastrointestinal cancer, with a focus on developing new prevention and treatment strategies for liver cancer. TGF-? controls many fundamental aspects of cell proliferation and differentiation. It plays a complex role in cancer. Mishra discovered that that the TGF-? pathway is the effector pathway for the human stem cell syndrome with an 800-fold risk of cancer (Beck-Wiedmann Syndrome), Science 2003,2005, PNAS, 2008, JCI, 2013, 2016, Hepatology 2017, Gastroenterology 2018, Cell 2018, Cancer Cell 2018, Cancer Research 2020, Gastroenterology, 2018, 2020, 2021. Her research has led to more than 374 peer review articles. Dr. Mishra has received many honors including American Gastroenterological Association Award for Top Women in Gastroenterology (2008); In 2016, she was elected Fellow of the American Association for the Advancement of Science (AAAS). In 2017, she was elected to the governing board of the American Association of Liver Diseases. In 2019 she was elected as a member of Association of American Physicians (AAP) and 2020 she received American Association for Cancer Research Team Science Award (AACR).
Lopa Mishra is currently a Professor of Medicine and Merinoff Endowed Chair, Co-Director for The Institute for Bioelectronic Medicine at The Feinstein Institutes for Medical Research, Northwell Health, and Cold Spring Harbor Laboratory. Current discoveries in Dr. Mishra’s laboratory have led to exciting new findings: Animal models with disruption of TGF-β develop fatty liver and cancers spontaneously on a regular diet reflective of current trends in cancer in the human population and it led to a patent. In addition, Animal models with disruption of TGF-β have an altered microbiome. Mishra discovered that the TGF-β pathway is the effector pathway for the human stem cell syndrome with an 800-fold risk of cancer (Beck-Wiedmann Syndrome). Her research has led to more than 374 peer review articles in Science 2003,2005, PNAS, 2008, JCI, 2013, 2016, Hepatology 2017, Gastroenterology 2018, Cell 2018, Cancer Cell 2018, Cancer Research 2020, Gastroenterology, 2018, 2020, 2021. Dr. Mishra has received many honors including American Gastroenterological Association Award for Top Women in Gastroenterology (2008); In 2016, she was elected Fellow of the American Association for the Advancement of Science (AAAS). In 2017, she was elected to the governing board of the American Association of Liver Diseases. In 2019 she was elected as a member of the Association of American Physicians (AAP) and in 2020 she received the American Association for Cancer Research Team Science Award (AACR).
Dr. Taub has more than 20 years of experience leading drug development, including roles as Senior Vice President of R&D at VIA Pharmaceuticals, Vice President of Metabolic Disease Research at Hoffmann-La Roche, and leadership roles at Bristol Myers Squibb and DuPont Pharmaceuticals. She was also tenured Professor of Genetics and Medicine at the University of Pennsylvania and a Howard Hughes Investigator.
I completed my medical degree at University College London in 2018 with an intercalated BSc in Global Health. I have since completed my foundation training and a junior clinical fellowship in hepatology and liver transplant medicine in 2019/20. I am now my 2nd year of a PhD at Queen Mary University of London. As part of my PhD, I am the clinical research fellow for a multi-centre, prospective clinical study to determine whether the urinary steroid metabolome can be used to diagnose and stage NAFLD. I have had posters at both national and international conferences, most recently winning a best poster award at the International Digestive Endoscopy Network 2021. I have recently been awarded a Coventon Scholarship by the Barts Voluntary Hospital Board to further analyse the urinary steroid metabolome in patients of South Asian ethnicity.
Juergen Eckel is a Professor of Clinical Biochemistry and he has been working at the German Diabetes Center in Düsseldorf since 1978. His field of study includes insulin signaling, insulin resistance, type 2 diabetes, obesity, adipose tissue and skeletal muscle biology, and organ crosstalk. His research group was the first to directly demonstrate the communication between human adipocytes and skeletal muscle cells. From 2006 to 2011, Prof. Eckel worked as the Acting Director of the Institute of Clinical Biochemistry and Pathobiochemistry at the German Diabetes Center. From 2011 to 2016 he directed the Paul-Langerhans-Group for Integrative Physiology. Prof. Eckel served as a chairperson for several EU COST Actions between 2000 and 2011 and coordinated the EU FP7 project ADAPT. He received several awards and published more than 300 original papers and reviews. Since 2021 he serves as CEO of CureDiab.
Dr. Rutger Fick is a seasoned AI professional and a respected leader in the field. As the Senior AI Lead at Tribun Health, he is responsible for overseeing the technical and scientific endeavors of the AI department. With his extensive background in medical domains, he has a unique understanding of how AI can be used to improve healthcare. Dr. Fick holds a PhD in diffusion MRI imaging of the brain, which has equipped him with a deep knowledge of medical imaging and its applications. Before joining Tribun Health, he worked in AI-driven radiotherapy treatment optimization, where he used AI to help improve the efficacy of cancer treatments. These experiences have given him a wealth of expertise in medical AI and its potential to transform healthcare. At Tribun Health, Dr. Fick’s mission is to use AI to create better data-driven tools for pathology diagnosis. He is a self-described problem solver who thrives on finding solutions to complex challenges. He is passionate about using AI to facilitate more accurate and efficient diagnoses, which can lead to better patient outcomes.
Diana is a clinical development leader with over 20 years of experience in drug development and in building teams to support clinical development programs. Currently, Diana is Chief Development Officer at Terns where she provides strategic and operational planning for clinical development programs and supports building the appropriate infrastructure to support R&D efforts. She joined Terns from Gilead Sciences where she led and built the early development and biomarker operations team, focusing on excellence in Phase 1 clinical study design and execution as well as efficient incorporation of biomarkers into clinical trials. In addition, she led the clinical operations Inflammation and HIV and Emerging Viral Infections therapeutic areas. During her tenure at Gilead, she was involved in nine US and ROW drug approvals. Prior to Gilead, she held roles in clinical operations at Roche/Genentech, Theravance and XenoPort.
Tooploox is an AI software development company providing custom AI solutions and services for innovative companies and startups. Since 2017, our R&D team of 40+ engineers has been at the forefront of AI, delivering tailored solutions across industries like healthcare, life sciences, fashion, and e-commerce. We design, build, and test products that align with clients’ visions. Ready to transform your business with AI? Visit www.tooploox.com or email matt@tooploox.com for a call.
BioTuring is excited to launch SpatialX, a multi-image & technology spatial data analysis software. We are an innovative bioinformatics company that seamlessly integrates with many data platforms to provide in-depth knowledge to empower researchers and scientists. Founded in 2016, BioTuring has developed transformational bioinformatics platforms for sequencing data analysis and gaining valuable insights from biological data in an interactive, fast, and accurate approach. Visit us at Booth #3 for an exclusive demo of SpatialX.
Sciento maximises the value of your most important asset – your people, by creating cloud-based IT solutions purpose-built for the life sciences sector.
Our company develops Slide Score, a web-based digital pathology platform with case report forms. Pathologists can annotate, score, and share whole slide images and TMAs up to 40% faster, without the hassle of figuring out which slides need to be scored for what. Teachers can create interactive e-learning modules for histology classes or trainings. Try our integrated AI workflows for segmentation or IHC quantification, or let us show you how easy it is to add your own.
For sponsorship package & exhibit your products and services kindly contact Reuben at reuben@global-engage.com
For sponsorship package & exhibit your products and services kindly contact Reuben at reuben@global-engage.com
For sponsorship package & exhibit your products and services kindly contact Reuben at reuben@global-engage.com
For sponsorship package & exhibit your products and services kindly contact Reuben at reuben@global-engage.com
Modella AI has created advanced generative and agentic AI tools using multi-modal foundation models, enhancing accuracy and efficiency in medical imaging analysis, particularly in pathology. These tools leverage extensive datasets of pathology images and clinical data to train AI systems for various tasks. Modella AI is pioneering the introduction of generative AI copilots and agentic research assistants, which support pathologists by automating routine tasks, generating detailed reports, and offering biomarker insights based on the latest medical research.
Probiotic Solutions Across Industries – Discover Unibio Probiotics
Unibio is a pioneer in probiotics industry, with a library of 30,000+ strains, 10+ clinicals and 100+ patented strains for diverse health position.
With 40+ years of research and our unique VPro® 5-layer micro-encapsulation technology, we have a vast knowledge base to turn your idea into real products. We offer,
HelpGut® Human Clinical Probiotics
ProLipo® postbiotics
HelpGut® formulation solutions
Next generation probiotics Akkermansia muciniphila
Meet us @ exhibition area. See you soon!
Histomography provides high-resolution 3D imaging for paraffin-embedded tissue samples. Optimizing X-ray phase-contrast tomography, we visualize three-dimensional structures non-destructively and without staining, offering new insights for medical and biological research. We develop and distribute an easy-to-use one-click lab device and also offer easy access to our imaging services.
Grundium is a global leader in digital imaging for pathology, reshaping how medical professionals diagnose and treat diseases. The company leverages decades of expertise in optics and imaging to develop the Ocus® series microscope scanners. Trusted by healthcare providers worldwide, these compact, high-precision devices make high-quality digital and remote pathology accessible to all, offering ease of use and affordability for laboratories of any size.
Everlife-Chemoscience has been supplying Singapore’s clinical and scientific communities with comprehensive diagnostic and scientific solutions for decades. We Enable Better Outcomes in Health and Science by providing laboratories with the best product technologies and services. Our deep understanding of the local market, strong technical expertise and commercial networks have helped us become a leading solutions platform in Singapore, covering 3 major segments: Clinical diagnostics, Analytical and Industrial Solutions and Life Sciences.
Founded in 1915, Yokogawa Electric Corporation is a leading company in industrial automation and control systems, structured into three key segments: energy and sustainability, materials, and life sciences. In our life sciences division, we recently achieved a breakthrough in DNA-free genome editing in plants using our nano-delivery system. With this innovation, we aim to contribute to the development of new crop varieties and addressing global food challenges.
At GE HealthCare, we see possibilities through innovation. We’re partnering with our customers to fulfil healthcare’s greatest potential through groundbreaking medical technology, intelligent devices, and care solutions. Better tools enable better patient care. Together, we are building a healthier future and living our purpose to create a world where healthcare has no limits.
Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single-cell spatial genomics. These tools enable researchers to gain new insight into the biological systems that govern human health and disease with spatial context. Vizgen’s MERSCOPE® Platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivaled detection efficiency at subcellular resolution.
Kaneka Corporation, established in 1949, is a leading technology-driven company headquartered in Osaka and Tokyo, Japan. Kaneka is providing an array of innovative solutions to diverse markets worldwide. Kaneka focuses on four strategic solutions units: materials, quality of life, health care, and nutrition. Plant Biotechnology(PBT) Unit is one of units in food production support strategic unit. PBT Unit is trying to develop innovative technologies to provide the solutions to the global food insecurity.
Handsome Investment Group Co., Ltd. is a private group founded in 2000, with headquarters in Dongguan Songshan Lake Hi-Tech Industrial Development Zone, GuangDong Province, China. The company operates in various industries including bio-technology, real estate, hotel & tourism, and investment.
Handsome Investment Group has ventured into investments, targeting high-quality enterprises across the industrial chains in line with its strategic objectives. The group has made successful investments in several high-growth companies. Furthermore, Handsome Group has realized significant gains in the secondary market and is now among the top ten shareholders in multiple listed companies.
As angel investors, we engage in equity investments and establish joint ventures. Our primary focus is on identifying potential collaborations with Handsome Investment Group’s existing business activities, rather than on the project’s current revenue generation.
Welcome to Conference Inc, your ultimate resource for finding and participating in international conferences, seminars, and journals. Our platform is designed to cater to researchers, academics, and professionals across various fields, ensuring you have access to the most comprehensive and up-to-date information. Explore the list of conferences & seminars 2024, 2025, and take your research and professional development to the next level.
Singpath Medical is a leading pathology solution company dedicated to advancing healthcare through innovative diagnostics products in the fields of: conventional pathology, liquid-based cytology (LBP), and polymerase chain reaction, (PCR), immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), digital pathology and other technical platforms. As the first listed company in the field of pathological diagnosis in Singapore, our team is committed to constantly innovate and develop high-quality solutions for pathologists
As a business unit of Motic, a leader in the field of optics since 1988, we are part of a global company innovating for a better tomorrow. Our whole slide scanning and image management systems have now been deployed for millions of cases worldwide, and our philanthropic initiatives leverage digital pathology technologies to solve today’s most pressing and under-resourced health problems.
Biolog has the tools, services, and support to provide the microbial phenotypic characterization and polyphasic identification capabilities required to produce functionally relevant insights. Our products and services enable characterization of microbial and mammalian cells as well as identification of thousands of species of bacteria, yeast, and fungi. Learn more at www.biolog.com.
Conference Locate (Clocate) is a leading international directory for worldwide conferences and exhibitions. Conference Locate (Clocate) is equipped with a unique and comprehensive search that helps you find easily any event in any category or location. Each event includes detailed information, like, description, dates, location, map, prices, link to the event’s website and more…
If you search for a conference or exhibition in areas such as Industry and manufacturing, Health and medicine, Technology and IT, Business and finance, sciences, education, services (banking, insurance, tourism, Hospitality and more), government, environment, life style and arts, you’ll find it in Conference Locate (Clocate).
KC Microbiome Communications Group is an agency that offers writing and communications services specifically related to the microbiome, probiotics/prebiotics, microbial therapeutics, and medical microbiology. Headquartered in British Columbia (Canada) and led by Principal Kristina Campbell (M. Sc), KC Microbiome Communications Group is a set of exceptional professionals living all over Canada and the world. We are proud to offer clients a way to access the world’s best talent specifically related to microbiome science communications.
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology that is currently used for real-time, accurate, and scalable analysis of DNA and RNA. The technology is used in more than 120 countries, to understand the biology of humans, plants, animals, bacteria, viruses, and environments as well as understand diseases such as cancer.
Sciencewerke Pte Ltd
Sciencewerke is a specialized biomedical and life science solutions provider, dedicated to delivering cutting-edge technologies for Cellomics, Genomics, Proteomics and Bio-imaging research. Leveraging our expertise and a curated portfolio of high-quality products and premium services, we provide tailored solutions to researchers, clinicians, and industry professionals in the life sciences, pharmaceutical, and clinical diagnostic sectors. With ISO 9001:2008 certification and GDPMDS accreditation, we deliver on our commitment to quality and excellence in all products and services.
Website: www.sciencewerke.com
Element Biosciences
Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multi-omics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries.
Website: www.elementbiosciences.com
Antaros Medical is an imaging CRO, combining imaging expertise with extensive knowledge in drug development and disease biology to design and deliver clinical trials for decision-making and differentiation in drug development. With global collaborations with pharmaceutical companies across metabolic, fibrotic and inflammatory diseases, Antaros Medical is providing key answers in every stage of clinical drug development, from early to late-stage clinical trials. Antaros Medical’s headquarter and corelab is based in Sweden, with a subsidiary.
LG Business Solution is total Business Solution provider offering a diverse portfolio of IT products to ensure your success.
With years of experience in the field of display technology and a product range includes Medical Display, LG Medical Display can improve your productivity levels and help your business by constantly developing in-step with advanced technology. Come join us at #34 to see our impressive range of Medical Display firsthand, we’d love to have you there!
KFBIO focuses on digital pathology and provides end-to-end digital pathology solutions. KFBIO has been in the digital pathology industry for 13 years, and has developed five business segments including the digital pathology slide scanners, telepathology platform, pathology AI, routine pathology equipment and pathology diagnosis services, providing the most complete end-to-end digital pathology solution to meet different needs of customers.
The Singleron Singapore team has served the APAC research community with single-cell multi-omics solutions since 2018, offering products and services in tissue preservation, dissociation, library preparation, and bioinformatics. For more information, visit https://singleron.bio
As a global leader in R&D genomics, GENEWIZ from Azenta Life Sciences offers Multiomics and Synthesis services that streamline your journey to discover tomorrow’s solutions faster. Azenta seamlessly integrates into your workflow with our complete NGS solutions for virtually any application. For more information, visit https://www.genewiz.com/
CYTENA single-cell dispenser is equipped with precision microfluidic for high single-cell dispensing efficiency. Equipped with Automated Offset Correction (AOC), we can achieve high precision single-cell deposition into PCR plate, thus enabling downstream miniaturization of NGS library preparation. Together with our centrifugal plate washer and nanolitre non-contact liquid dispenser, we offer an automated solution for high-quality libraries with minimal manual intervention, leading to reduction of variability while improving reproducibility and increasing throughput of your sequencing experiments.
TransCure bioServices pioneers preclinical research with cutting-edge humanized liver models and customized solutions for drug discovery in metabolic-associated liver disease (MASLD) and beyond. Our reliable, humanized mouse models and tailored study designs accelerate your research outcomes. Come and visit us to explore how we can support your next breakthrough!
https://transcurebioservices.com/
NovogeneAIT Genomics is a leading multi-omics services and solutions provider headquartered in Singapore. It is formed as a strategic joint venture between Novogene and AITbiotech, a Singapore biotech Company in 2016. Operating from our state-of-the-art sequencing center in Singapore, NovogeneAIT is dedicated to advancing genomic research by offering unmatched data quality that empowers researchers across diverse sectors, including healthcare and agriculture, to realize their research goals. For more information, visit www.novogene.com/amea-en/
NanoString’s Mission is to Map the Universe of Biology. As the pioneer in the field of spatial biology, NanoString enables scientists across the globe to envision molecular interactions in 3 dimensions with 3 different systems, nCounter, GeoMx DSP and CosMx SMI platform. As a result, scientists can see the multiomic expression of genes and proteins in the natural context of tissue structure. With our technologies, our customers continue to extend our understanding of biology to answer previously unsolvable questions with consistent, reliable results.
www.bio-equip.com was established in the early days of the Internet, in July 1998. Over the last two decades, themed on ¡°serving life sciences and serving high quality suppliers¡±, Bio-equip has provided the users in the fields of life sciences, medicine research, biological pharmacy, bio-engineering, modern agriculture, food safety, environmental monitoring and forensic science with the industrial information in terms of devices and instruments, reagents, consumables, lab animals, cell lines, books, biological R&D service, second-hand instruments and instrument repairs.
There are two versions, the Chinese version (bio-equip.com) and English version (bio-equip.cn): So far over 30,000 companies have registered as members and provided over 1 million product entries in the Chinese version (www.bio-equip.com), The daily visits exceed over 60,000.. The English version (www.bio-equip.cn), established in 2006, is the only English website in this field. Until August 2018, over 1,000 companies from both at home and abroad have registered as members, covering the fields of manufacturing, sale and agency of instruments/reagents with over 100,000 product entries.
Sierra® technology from PathQA provides colour accuracy reporting for digital pathology quality assurance and standardizes colour for WSI scanners, viewers and scanner-agnostic AI validation using high-fidelity ICC profiles.
The Sierra Slide with VS-Profiler software measures, calibrates and regulates digital pathology scanners and images to the real ground-truth colour of histopathology.
Standardization of digital colour to the validity of real glass slides delivers true QA.
PathQA – Quality as Standard
PredxBio is harnessing spatial multi-omics powered by spatial computing to unravel the complexities of the tumor microenvironment. Our explainable AI elucidates the underlying mechanisms of cancer, achieving unparalleled accuracy exceeding 90% in predicting treatment responses across critical cancers. From multiplexed biopsy images to unveiling network biology pathways, PredxBio’s innovative solutions offer unprecedented insights into cancer biology, improving the understanding of the immunological responses to drugs and enabling the development of spatial prognostic/predictive biomarkers. Explore our groundbreaking SpaceIQ™ platform at com.
BGI Genomics is one of the world’s leading providers of sequencing and mass spectrometry services, now serving customers in more than 100 countries and regions around the world. We have more than 20 years of genomics experience helping our customers achieve their research goals by delivering rapid, high-quality results using a broad array of cost-effective, cutting-edge technologies. Contact us to find out how we can assist with your project, we’re confident we can help.
Pathomics.ai is driven to transform the landscape of spatial biology by delivering product solutions which demystify complex imaging data. We uncover the complexity of biological systems through advanced computational techniques to accurately visualize and analyze spatial relationships between cells, tissues, and molecules. Pathomics.ai utilizes interdisciplinary approaches that combine biology, physics, mathematics, computer science, and engineering. Through our customized and holistic approach to image analysis, we have developed techniques for image analysis, data modeling, and spatial statistics. Simply put, Pathomics.ai—We Analyze Images.
Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
Our growing portfolio of products includes Evercode Whole Transcriptome, Evercode TCR, Gene Capture, and a software tool for data analysis.
Future-proof your lab’s cassette printing with the LaserTrack FLEX cassette printer from General Data Healthcare. The LaserTrack FLEX offers different options – including printing on one to three sides of the cassette – customized to your lab’s needs. The FLEX can be upgraded without sacrificing functionality or replacing the printer. General Data’s histology and lab sciences solutions include everything your lab needs for increased operational efficiency, reliable identification, advanced patient safety and highly accurate results.
Singular specializes in advanced NGS and high throughput spatial multi-omic technologies. The G4 Sequencing Platform, our first commercially available product, is a benchtop sequencer featuring a novel 4-color rapid sequencing-by-synthesis (SBS) chemistry, providing single-day turnaround times for all sequencing applications. Our recently launched G4X Spatial Sequencer, an upgrade to the G4 Sequencing Platform, is designed to offer in situ direct sequencing of RNA (Direct-Seq™), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues.
Sensors & Diagnostics is the first journal to publish innovative research in the field of sensors as well as diagnostics, molecular imaging and molecular therapeutics. We made the journal gold open access to ensure that key results from the lab can effectively reach and benefit multiple research communities. And we are proud to contribute towards the UN’s third sustainable development goal – to ensure healthy lives and promote well-being for all at every age.
Molecular Omics publishes high-quality research in the -omics sciences. We welcome scientific research based on the application of any -omics technology and we encourage multi-omics approaches to solving important chemical or biological problems. This includes combining different types of omics platforms encompassing genomics, transcriptomics, proteomics, metabolomics and other specialized areas such as glycomics and lipidomics, as well as innovative bioinformatics approaches.
Applikate provides an elegant solution to the difficult and time-consuming problems faced by pathologists and their staff. The company’s clearing histology with multiphoton microscopy platform renders microscope slides obsolete and offers a revolutionary approach to histology without requiring new skills, extensive training, or prohibitive costs. For hospital administrators, managers, and decision makers, Applikate creates a unique opportunity to reduce processing costs significantly while improving diagnostic collaboration. The system has not yet been cleared by the FDA for diagnostic use and is currently for Research Use Only.
Indica Labs is the global leader in AI-powered digital pathology software and services. Our flagship HALO® and HALO AI platform revolutionizes quantitative evaluation of whole slide images. HALO Link provides collaborative image management while HALO AP® and HALO AP Dx deliver enterprise digital pathology for primary diagnosis. Our Pharma Services and Cloud Services offerings support pharma, life science, and clinical sectors through tailored image analysis solutions and deployment options.
Launched in 2013, Ambpomial (originated from “ambrosial”, which means ambrosial yogurt) has become the leading yogurt brand in China. By continuously innovating its products and marketing toward young consumers, Ambpomial is helping to set new industry trends. With its rich flavor and high protein content, Ambpomial has defined high-quality, nutrition-focused yogurt.
Perseus Biomics develops DynaMAP, a novel and uncompromised metagenomic method. It uses DNA fluorocoding and optical mapping to profile complex microbiomes down to strain level in just a few hours and at a price point competitive to amplicon sequencing. Speed, taxonomic resolution and cost-efficiency, DynaMAP has it all, unlike the cost/performance trade-offs between 16S and Shotgun. DynaMAP accelerates microbiome profiling and remove bottlenecks in pre-clinical studies, precision nutrition and clinical applications.
At Enable Medicine, our mission is to organize and make searchable the world’s biological data to accelerate discovery and better patient outcomes. We’re building the largest, most comprehensive biological atlas to index, integrate, and interrogate vast, multimodal datasets. On Enable Medicine’s platform, scientists leverage computational power of AI to search these atlases and unlock deeper insights. For more on how AI-powered biological search can power the next generation of diagnostics and therapeutics, visit http://www.enablemedicine.com.
SEQme translates advanced microbiome sequencing solutions into transformative applications in healthcare, veterinary medicine, water management and agriculture, we offer cutting-edge solutions to analyse and understand microbial communities. Our expertise supports clients in improving patient outcomes, enhancing water quality, and increasing agricultural productivity through precise, data-driven insights into the microbiome. The company is ready to offer current workflows for periodontium microbiome examination, soil microbiome analyses and water microbiome monitoring.
Our mission is to bring the power of mass spectrometry to everyone. We help startups and established businesses advance in their field of R&D by providing actionable insights and answers to their research questions. Arome provides expertise, knowledge, platforms and protocols to drive our clients’ R&D forward and advance their products and services. Most recently, we have patented two products for efficient, accurate, and trouble-free collection, extraction, and analysis of urine and fecal samples.
Dxome CLIA is a CLIA-certified and CAP-accredited laboratory located in Irvine, CA providing CRO services for the CosMx platform, the highest-plex, single-cell spatial profiling system. We are specialized and focused on CosMx spatial profiling, and work closely with our academic researchers and biopharma customers to design projects that meet their needs and generate new insights to advance their research.
At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy DNA and RNA sequence data in studies around the globe. The innovative products that we provide are helping drive advancements in a multiomic understanding of cellular functions, combining transcriptomics, epigenetics, and proteomics. Multiomics profiling studies enable a more comprehensive understanding of development, cellular response, and disease, fueling the discovery of novel drug targets and biomarkers. The progress our customers have made and what lies ahead inspire us to push the boundaries of what is possible so we can create the next generation of genomics solutions.
BioBunBan is an advanced bio-technology company, with capabilities to produce high quality bio-material, to support our business partner produce special function/indication of probiotics food products/live probiotics pharmaceuticals. We also possess plant cell fermentation technique which can mass-production of high value plant cells lyophilized powder and end products. At this moments we have Snow Lotus, Rice Cells and Rose Cells can be utilized into consumer end products, food or daily cosmetics.
BioChain Institute is an emerging end-to-end spatial biology service provider with multiple spatial transcriptomics and proteomics solutions including 10x Genomics CytAssist, Xenium, NanoString GeoMx — all under one roof. A trusted leader in high-quality biospecimen procurement and sample analysis for pharmaceutical and biotechnology companies since 1994, BioChain also provides sample preparation kits, automatable nucleic acid extraction machines, cell culture and histopathology services.
Lux Research delivers research and advisory services to inspire, illuminate, and ignite innovative thinking that reshapes and grows businesses. We are the leading provider of sustainable innovation research and advisory services, helping clients drive growth through insights on novel sciences, emerging technology, and consumer trends.
Envisioning a future of precision healthcare
Perspectum is an innovative company in the field of precision health technology delivering advanced solutions to health care providers. Our best-in-class technology is noninvasive and generates clear and understandable reports aiding clinical decision-making as well as supporting patient engagement.
Eye-2-Eye Communications Pte Ltd is a market leader for Medical and Enterprise Imaging in Singapore and Indonesia.
We are the authorized distributor for:
Barco Medical Displays for radiology and digital pathology
Nexxis Live medical video streaming
Hyland’s Enterprise Imaging
Rimage CD/DVD/USB Publishers
Perennity Medical Image Portal.
We also distribute Formlabs 3D Printers in the above countries and Malaysia, and
offer the most advanced and comprehensive 3D design-to-manufacturing solutions
in medical, dental and orthotics.
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet.
ATCC (American Type Culture Collection) is a private, nonprofit, global biological resource center and standards organization that provides scientists with the world’s largest and most diverse collection of human and animal cell products, as well as molecular genomic tools, microbe products, and biological materials. Chemoscience is the official distributor of ATCC products in Singapore, Philippines, and Indonesia. We enable better outcomes in health and science by providing laboratories with the best product technologies and services.
DKSH Technology, Scientific Instrumentation, provides full scientific solutions consisting of high-end life science, analytical, and general laboratory equipment and consumables. We offer our customers total solutions that help to solve complex challenges, improve results, and increase productivity throughout the products’ lifespan. Besides servicing your instruments, we also do sample testing, conduct application trainings to help you understand the equipment to fully utilize it for your applications.
MicrobiomePost is the global destination for healthcare professionals and companies in the microbiome field. It provides breaking scientific updates about the latest research discoveries and corporate news. MicrobiomePost subscription it’s free and gives you unlimited access to the scientific contents.
At QACS Lab, we’ve provided trusted laboratory testing solutions since 2002, serving Cosmetic, Pharmaceutical, Disinfectant, Medical Devices, and Food industries. Our analytical testing services in Microbiology, Chemistry, and Molecular Biology ensure product efficacy, safety, and regulatory compliance. With experienced scientists, we guide clients through product development. Our labs are GMP & GLP certified, FDA registered, and ISO 17025 & ISO 9001 accredited, making QACS your accredited Laboratory Testing partner.
With 20+ years of experience in high-quality, non-invasive biological sample collection and stabilization of nucleic acids, DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc., offers high-quality self-collection devices for microbiome research. The DNA Genotek™ OMNIgene™ and OMNImet™ collection device product lines immediately stabilize microbiota and metabolite samples at the point-of-collection, ensuring accurate downstream results. Providing self-collection kits for stool, oral, skin, vaginal, and animal samples DNA Genotek™ is dedicated to increasing access to participants and delivering analytes for actionable insights in microbiomics, metabolomics and transcriptomics.
GE, Targetting Microbiota, UK One Health
As a leading organisation in the biomedical and life sciences industry, Biomed Global aims to raise the quality of healthcare and facilitate medical breakthroughs. Spanning over 20 years of experience, we have created a synergy to bring innovative medical solutions and people together. We actively service multiple healthcare institutions such as government hospitals, private hospitals, commercial labs, academic and private research institutes. Specialising in Microbiology, Haematology, Immunology, Blood Banking, Molecular Biology, and Life Sciences, we have positively impacted numerous lives throughout Southeast Asia and more.
Microbiome Research Reports (MRR) is an international peer-reviewed, open access journal. All articles published by MRR are made freely and permanently accessible online immediately from the date of publication.
The scope of the journal includes investigations of microbiomes present in one or various body compartments of human beings or other animals. Surveys on the establishment of microbial communities as well as on microbe-microbe interactions and microbe-host communication will be considered for publication. The overall aim of MRR is to publish high quality researches from scientists with a common interest in microbiome/microbiota research in all its multidisciplinary aspects.
IDT is a global leader in CRISPR genome editing with a complete workflow from design to analysis. With a 41,000 square foot Therapeutic Oligonucleotide Manufacturing Facility, we provide the CRISPR cGMP guide RNA manufacturing grades to align with your development path, enabling you to move from preclinical to clinical phases. As your trusted partner, we are committed to providing you with the highest quality products and services to help accelerate your cell and gene therapy therapeutics.
BioPharma Asia aims to keep its readers abreast of all developments in Manufacturing, Development, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters associated with only end-user companies. So, ensuring the information is always guaranteed to remain timely, informative, and unbiased.
BPT Analytics (BiopharmaTrend) delivers drug discovery and biotech news, industry reports and interviews with key experts, along with technology scouting and market research services. We are exclusively dedicated to exploring the advent of novel technologies in life sciences and all things ‘tech & bio.’
Hep magazine and HepMag.com are the go-to sources for educational and social support for people living with liver diseases like hepatitis C, hepatitis B, hepatitis A and NASH. Launched in 2010, the website is devoted to combating the stigma and isolation surrounding liver diseases, and offers news, in-depth reporting, educational tools, care resources, and peer-to-peer networking.
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network for the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.
SeekGene BioSciences is an innovative enterprise that specializes in the independent development of single-cell technology. With a strong focus on creating high-throughput single-cell full-chain products, the company is committed to making this cutting-edge technology more accessible and widespread. SeekGene offers reliable high-quality single-cell products and laboratory construction solutions to global scientists, technology companies, pharmaceutical companies, and other customers.
Established in 2015 following its inception at Harvard University’s Wyss Institute for Bioinspired Engineering, Ultivue is a market leader in quantitative proteomic biomarker detection and advanced spatial tissue profiling. Through ultrasensitive InSituPlex® assays and advanced, AI-driven spatial analysis, Ultivue empowers scientists developing precision cancer therapies to generate quantitative, high confidence spatial insights in just a fraction of the time.
Leica Microsystems provides you with intelligent innovations in live-cell imaging. Our solutions help you get the best image quality while protecting your samples.
With the variety of fluorescent proteins and multicolored probes that have been developed, it is now possible to label virtually any molecule. The ability to visualize protein dynamics in vesicles, organelles, cells, and tissues has provided new insights into how cells function in healthy and disease states. These insights include the spatiotemporal dynamics of processes like mitosis, embryonic development, and cytoskeleton changes. When studying live cells, common obstacles include phototoxicity and photodamage. To capture fast biological processes, it is crucial to keep the cells healthy and obtain crisp images for reliable data that are free of artifacts. Live‐cell microscopy often requires a compromise between image quality and cell health. During imaging, certain environmental conditions must be maintained to avoid changes in the cells.
Probi® is a global company focused exclusively on researching, manufacturing, and delivering probiotics for supplements and functional food. We are experts at managing stable, live bacteria from R&D through every stage of the manufacturing process, and are dedicated to making the health-enhancing benefits of probiotics available to people everywhere. Our health concepts, formulations, and formats are supported by robust clinical documentation. Since our founding in 1991 at Sweden’s Lund University, Probi has expanded its operations to more than 40 markets. We hold more than 400 patents globally.
Meteor Biotech is a pioneering force in spatial genomics, dedicated to transforming cancer research through innovative technology. Our flagship product, CosmoSort, leverages advanced spatial omics to unlock unprecedented insights into tumor biology, enabling precise diagnosis and tailored treatment strategies. Committed to scientific excellence and collaboration, we aim to drive forward the boundaries of medical research for better patient outcomes. Visit us to explore the future of precision medicine.
Aseptic Technologies manufactures fill & finish equipment and devices for advanced pharmaceutical manufacturing. Our core expertise lays in the innovation of aseptic filling processes for biopharmaceutical products, including cell and gene therapy products.
As a member of SKAN Group, we leverage the technological excellence of SKAN in the isolator design, providing integrated solutions globally. We also have expertise in injection molding and manufacturing in cleanroom, offering customized ready-to-use assemblies for pharmaceutical processes.
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 47 billion components and devices each year.
Moving Health Forward Together
At Bionano, we strive to elevate health and wellness for all people through customer-centered innovations that transform the way the world sees the genome.
Our OGM systems, software solutions and uncompromising support allow you to reveal more genomic variation that matters across a variety of applications in clinical care, research and therapeutics.
Enhance your quality control and ensure the genomic integrity and stability of cell lines for producer cell lines, research cell lines and cell therapy applications.
Redefine Quality Control for Cell Bioprocessing with Optical Genome Mapping
Whether you are working with producer cell lines, research cell lines, or cell therapy applications, ensuring the genomic integrity and stability of your cell lines is of critical importance. Traditional cytogenetic methods have significant limitations in resolution, turnaround time, and scalability. Optical genome mapping (OGM) with the Bionano Saphyr® system is an advanced digital workflow that enables genome-wide analysis of structural variants (SVs) and copy number variants (CNVs), so you can easily screen cell lines for genomic instability and off-target events.
Screen your cell lines for all classes of structural variants in a single assay.
GenScript Biotech Corporation (HK.1548) is the world’s leading technology and service provider of life science R&D and manufacture. Built upon its solid gene synthesis technology, GenScript Biotech is divided into four major platforms including the life science service and product platform, the biologics contract development and manufacturing organization (CDMO) platform, the industrial synthetic products platform, and the integrated global cell therapy platform.
ILSI Europe, the European branch of the International Life Sciences Institute (ILSI), is a non-profit federation dedicated to collaborative science for safe, nutritious, and sustainable food. We foster collaboration among academic, industry, and public service experts to develop science-based guidance addressing food, public health, and sustainability challenges. Our deliverables include peer-reviewed publications, guidance documents, workshops, and symposia in food safety & quality, nutrition & health, and food security & sustainability.
TRI-K is a leading manufacturer of actives & specialty ingredients, bringing groundbreaking concepts and products to life for the cosmetics industry. TRI-K strives to keep ahead of the curve with a specialization in cosmetic proteins, amino acids, natural peptides, multi-functional actives and optimized solutions. We combine an awareness of consumer trends with our in-house development team to discover new raw materials that provide our customers with a consistent competitive advantage.
EXCILONE, a French company, offers solutions associated with Digital Pathology. Among them:
Visit us on our booth to discover our products and services.
Aisencia develops an advanced AI-based diagnostic platform for dermatopathology, ensuring fast and precise skin sample examinations for better healthcare. This fully digital solution enhances pathologists’ work, covering sample management, AI-assisted diagnoses, and automated report creation. Our innovative AI algorithm accurately analyzes histologically stained skin samples, aiding in diagnosing over 40 skin diseases with high precision. The integration of digital workflow and AI technology significantly improves diagnostic efficiency and quality, benefiting both patients and pathologists.
Ascenian is a global market access company in the field of price and reimbursement for new pharmaceutical treatments and medical devices. Identifying the right evidence to support reimbursement and price decision makers is the core business of Ascenian. We are located in the US and Europe.
Hepatoma Research is an international peer-reviewed, gold open access, online academic journal founded by OAE Publishing Inc. (www.oaepublish.com) in April 2015. The journal aims to provide the best academic exchange platform in the field of liver cancer, including its occurrence, development, diagnosis, and treatment. The coverage also extends to other basic and clinical studies related to surgery, internal medicine, cell biology, pathology, pathophysiology, immunology, genetics, pharmacology, etc. The journal is indexed in ESCI, Embase, Scopus and CAS, will get the first IF in June 2024. Visit our website (https://www.oaepublish.com/hr) to learn more.
The TalkingPoint Team develops process automation solutions to automate repetitive and time-consuming tasks, including integrating speech recognition within process orientated applications.
TalkingPoint has been a pioneer in the implementation of speech recognition technology within the UK healthcare market. From histopathology reporting solutions to enabling interoperability between digital pathology and AI systems, TalkingPoint is used across the NHS to maximise efficiencies and realise the benefits that technology has to offer.
Enabling trustworthy and privacy-preserving AI solutions.
Aignostics specializes in AI-powered pathology, uniquely combining proprietary technology, comprehensive data access, and world-class scientists to build bespoke AI models for its global biopharma clients. Aignostics delivers valuable insights into disease biology, supports translational research, and develops AI models for clinical trials. Aignostics is a spin-off from Charité Berlin, one of Europe’s largest university hospitals, has a multidisciplinary team of ca. 100 experts in Europe and the US, and is ISO13485 and ISO27001 certified.
HistologiX is a trusted GLP & GCP compliant CRO for tissue-based analysis – make the most of our expertise.
We help you visualise and understand what your drug or device is doing to key biomarkers at the cellular and tissue level. Working collaboratively, our experienced scientific team provides a bespoke service allowing you to make the most of our expertise in histology, immunohistochemistry including multiplex immunofluorescence, In Situ Hybridisation & cutting-edge digital image analysis using Visiopharm.
At Siemens Healthineers, we pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. As a leader in medical technology, we want to advance a world in which breakthroughs in healthcare create new possibilities with a minimal impact on our planet. By consistently bringing innovations to the market, we enable healthcare professionals to innovate personalised care, achieve operational excellence and transform the system of care.
Pairwise is pioneering the application of CRISPR technology in food and agriculture. The company brings together leaders in agriculture, technology, and consumer foods to harness the transformative potential of new genomics technologies to create innovative new products. Pairwise is working to develop new varieties of crops, and to partner with organizations that seek to deliver innovation across the plant-based economy.
European Pharmaceutical Students’ Association has a permanent office in Brussels and conducts its activities through regular congresses, training events, publications, campaigns, exchange programmes, collaboration with professional organisations, and virtual presence.
The vision of the Association is to represent, reach, and engage every single pharmaceutical student in Europe to collaborate on the development of the future of pharmacy and healthcare together.
The mission of the Association is to actively engage at student and professional levels, bringing pharmacy, knowledge, and students together while promoting personal development.
Human Metabolome Technologies (HMT) is a metabolomics profiling company that specializes in pre-clinical and clinical studies. HMT provides both targeted and untargeted profiling metabolite data for a wide range of applications from any sample type. HMT enables clients to understand critical pathways for biomarker discovery, enhance drug development, perform microbiome screening and uncover mechanisms of action through profiling of over 2,000 polar metabolites using high resolution, high performance CE-MS and LC-MS solutions for hundreds of lipophilic metabolites. HMT has been building a best in class metabolite profiling program with over 17 years of service to the research and medical community.
Copan is dedicated to developing and providing high-quality biological sample collection products for infectious diseases, microbiome analysis, forensics, and environmental control, along with automated platforms for the whole sample workflow management. To offer an efficient nucleic acid collection for microbiome analysis purposes, Copan developed a broad portfolio of sample collection devices and sample preparation systems that efficiently preserve DNA stability and guarantee maximum bacterial diversity recovery. Our newest device SMART-eNAT® inhibits microbial growth and DNA degradation, ensuring safe transport for prolonged periods at ambient temperature and unbiased microbiome profiling. Moreover, its innovative SMART post-collection activation system enables a clean and safe collection of nucleic acids, even at home. Copan range of innovative lab automation includes Cyclone™, the walk-away system specifically designed in compliance with ISO standards for microbiological quality control in the food and Cosmetics industries. Today Copan is still eager to continue this innovation, providing quality products, customized services, and prime solutions to improve the health and wellness of patients.
| DNA Genotek Inc. and Diversigen are subsidiaries of OraSure Technologies, Inc. offering high-quality microbial sample collection products and comprehensive services for sample processing, sequencing, and bioinformatic analysis. DNA Genotek’s OMNIgene product line immediately stabilizes microbiota samples at the point of collection, ensuring an unbiased ‘snapshot’ of the microbial community. Self-collection kits for stool, oral, skin, vaginal and animal sampling are available. Diversigen, who has sequenced more than 170,000 microbial samples, offers the best analytical science available to accelerate microbiome discovery for academic, pharmaceutical, biotechnology, agricultural and environmental applications. From study design to sample processing, data generation, and full custom analysis we ensure you get the most out of your data. |
| Isolation Bio Inc is the leading developer of a next-generation high-throughput isolation and cultivation platform for microbiome research and microbial product development. The Prospector® discovery platform integrates a highly dense array with nanoscale cultivation chambers that can grow hundreds of microcolonies in parallel with a bench-top system that automates and scales the most labor-intensive aspects of the microbiology workflow though software-driven imaging, picking, and transfer of single isolates into standard multi-well plates for downstream analysis. |
| Cerillo is a biotechnology company that enables transformative research through its platform of innovative hardware, software, and consumable products focused on the detection and interactions of microbes. |
As one of the leading venture capital firms in Europe, Seventure manages more than €1billion at the end of 2023. Since 1997, Seventure has been investing in innovative businesses with high growth potential in Life Sciences in Europe/US/Canada/Israel/Australia/South East Asia and Japan
In Life Sciences, Seventure’s preferred fields are:
• Microbiome
• Biotechnology and pharmaceuticals
• Nutrition & foodtech
• Connected & digital health and medtech & Dx
• Industrial biotechnology and cleantech
• Agtech
• blue economy
| Introducing ReciBioPharm, Recipharm’s biologics business combining the capabilities of acquired CDMOs Arranta Bio, GenIbet and Vibalogics. Our expanded biologics drug development and manufacturing services encompass technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, recombinant proteins, nucleic acid-based mRNA and plasmid DNA production. |
| Morinaga Nutritional Foods, Inc., a subsidiary of Morinaga Milk Industry Co., Ltd, has a philosophy to create a new food culture and make a difference in people’s health and society in general. We have been dedicated to providing high-quality health products, ranging from probiotics to soy products for food service and industrial use since our business began in 1985 in the US. |
Manda Group have been tackling to contribute to whole life through our products made by our unique fermentation technology. We manufacture and sales of Health Food Product, Fertilizer etc.
Burleigh Dodds Science Publishing is an award-winning independent publisher of content in agricultural and food science. Through our innovative publishing model, we bridge the knowledge gap between science and its application, empowering you to make a positive impact on sustainable agriculture, climate change and the UN Sustainable Development Goals as a result.
Accelerating your journey from samples to solutions. Gencove is unlocking the value of genetic data, enabling the most ambitious applications of genomics across industries, with an integrated platform for genomic data generation, analysis, and management.
Tropic is a pioneering agricultural biotechnology company dedicated to developing healthier, more robust, high-performing varieties of tropical crops with a vision to become a world leading technology-forward seed business. Tropic’s core focus is on banana, coffee and rice, utilizing our proprietary Gene-Editing induced Gene-Silencing (GEiGS®) technology to develop crops with increased disease resistance, improved yield, and sustainability traits. Tropic also partners with companies around the world for development of traits with GEiGS® in non-tropical crops.
L7 Informatics reimagines data intelligence for modern life sciences and healthcare organizations. Beyond simple data management, L7 provides tools that optimize the flow of information between process and people, unlocking innovation at every stage of the clinical, research, and manufacturing value chains. Our comprehensive operating environment and software stack bring flexible, secure, and collaborative data intelligence to your entire operation. From regulatory compliance and workflow orchestration to customized applications and integrations, our end-to-end transformation engine helps organizations solve the challenges of today and realize the opportunities of tomorrow.
Biomarker Technologies (BMKGENE) is a global industry-leading genomics service provider, headquartered in Beijing, China. We deliver professional Next-generation and Third-generation sequencing solutions for genomics, transcriptomics, epigenomics and microbiomics, with unrivalled efficiency, data quality and continuous technical support using the latest Illumina, Pacbio and Nanopore platforms.
G2 Speech provides market-leading, AI-powered speech technology and workflow management solutions to pathology departments globally. Optimising digital pathology reporting with Deep Learning and Neural Networks based technology. Supporting optimal productivity and streamlined reporting. With over 25 years of experience in the healthcare sector and supporting some of the world’s biggest pathology departments. Every day, over 45,000 medical professionals use our solutions to automate their reporting processes.
Zenopa specialise in recruiting commercial, engineering and laboratory positions within the IVD market, with specific expertise in Digital Pathology from entry-level to c-suite across the UK, EU and USA.
Our team take time to understand your specific recruitment pain points, challenges and requirements. We consult and advise on market conditions to give transparency throughout the recruitment process and achieve the desired outcome quickly, ensuring that your business strategy is not compromised.
At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma and pathology laboratories — aiming to provide invaluable insights for biomarker discovery and drug development, and to improve laboratory workflows.
Pathomation is a software company building digital pathology solutions for education, biomarker training, research labs and routine diagnostic labs.
Pathomation offers an Image Management System with different components which can be combined to create your unique digital pathology management and workflow solution. Whether you start from scratch; or already have a CMS/LMS/(AP)LI(M)S/PACS in place, we can integrate and tailor to your specific needs.
Additionally, we support virtually any WSI file format available in the market and are CE-IVD certified for all these image formats. Pathomation products are vendor and format agnostic, avoiding the risk of vendor lock-in, high costs and limited flexibility for future digital pathology applications.
If you have custom projects for digital pathology, please note our software is built with developers in mind. Our webservice-based API and various SDKs spare developers from having to rewrite digital pathology features from scratch.
Standard BioTools™, Improving human health through innovative medicines is your mission. Our mission is to provide you with the right, reliable products to solve your problems. The distributor for Microfluidics technology in Thailand is Genomax Technologies Co., Ltd. They have a mission to provide life science research communities, biotechnology & pharmaceutical companies, clinical research organizations, and hospitals in Thailand, Singapore, Malaysia and South East Asia with innovative and effective products and services.
Histofy develops vendor-agnostic transparent AI solutions for cellular pathology workflows with applications to rapid diagnosis and treatment of tissue pathologies, including cancer, and for accelerated discovery of drugs and biomarkers. Our team excels in technology development from concept to validation, bringing cutting-edge AI to clinical and pharmaceutical workflows.
DTM Medical is an international OEM and solutions provider based in Germany that combines specialist printing solutions with powerful software to create new solutions specifically designed for the medical market. We offer slide and cassette printers using either UV laser or thermal transfer printing technology for an efficient and reliable sample identification in pathology, cytology and histology laboratories. They are available as stand-alone or completely automated systems and can easily be integrated into existing LIS.
pfm medical UK, known in the UK as exclusive supplier of FEATHER® blades also manufacture our own German, pfm medical equipment including microtomes, water baths, cooling plates and exciting innovations such as Bluetooth, wireless, embedding forceps. We aim to provide a portfolio of products capable of producing high quality tissue sections with ease and precision and most importantly, user confidence. Come by and see the DTM TCP450 Cassette Printer designed to integrate with and support digital pathology workflows.
Sonrai unlocks the potential of our partner’s data to discover and develop drug candidates, novel biomarkers and clinical algorithms with life-saving potential.
Sonrai Discovery: Our cloud-based AI technology accelerates precision drug and therapeutic target discovery and development and enables more accurate and personalised patient treatment options.
Sonrai Diagnostics: Our advanced AI and machine learning algorithms, combined with our expertise in assay development, imaging, and regulatory compliance, empowers our partners to revolutionise pathology workflows and accelerate test development and launch.
Sysmex UK has been the distributors for 3DHISTECH digital pathology solutions since 2014. One consistent feature of the 3DHISTECH product range has been the regular release of new and ground-breaking instruments. Recently, Sysmex UK launched the PANNORAMIC® 480 high-end slide scanner. The P480 is the latest in a long line of high quality, innovative, digital pathology solutions to be developed by 3DHISTECH and is ideal for the busy NHS Cellular Pathology laboratory with innovative workflow design (such as the scanning of normal and mega-slides simultaneously in random access) and intuitive, user-friendly operating software.
At BT we’ve stood shoulder-to-shoulder with the NHS since 1948. Today, with healthcare services facing deep cost pressures and increasingly complex demands, we’re partnering with the NHS to pioneer innovations to tackle these challenges.
Led by our Clinical Board, we’re unleashing the power of connectivity, data, and digital innovation to deliver collaborative, cost-effective care, wherever needed. Innovating together. Transforming care.
Azenta is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services for the industry’s top agriculture/food science, pharmaceutical, biotech, academic and healthcare institutions globally. GENEWIZ by Azenta services include a wide variety of synthesis and sequencing services specifically for agrigenomics that allow for the optimization of productivity, nutrition and viability of many agricultural products.
Zymo Research is a globally established biotechnology company and industry leader in the fields of epigenetics, microbiomics and the emerging Next-Gen Sequencing space. Even with the most technologically advanced products in the industry, everything is driven by the fundamental belief that “the beauty of science is to make things simple.
X-omics is a National Roadmap Large-Scale Research Infrastructure, partially funded by NWO with a budget of 40 million euro. X-omics aims to establish a multi-omics research infrastructure across the Netherlands, by combining technologies in the field of genomics, proteomics, metabolomics and data analysis, integration & stewardship. With this infrastructure biomedical problems can be solved using an integrated approach.
Two major goals are:
WCG delivers transformational solutions that achieve quality outcomes and maximize efficiency in Endpoint Adjudication and Data Monitoring Committees. WCG is proud to support the industry’s top ongoing clinical trials in the NASH space by helping to lower the risk of variation and reduce inconsistencies or bias in clinical trial data to the regulatory agencies.
Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single-cell spatial genomics. These tools enable researchers to gain new insight into the biological systems that govern human health and disease with spatial context. Vizgen’s MERSCOPE® Platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivaled detection efficiency at subcellular resolution. For more information, go to www.vizgen.com
Visiopharm® is a leading provider of AI-driven precision pathology software for research and diagnostics. In research, it is a technology leader providing tools that help scientists, pathologists, and image analysis experts produce accurate data for all types of tissue-based research. In diagnostics, it is a leader within clinical applications, with eight diagnostic algorithms cleared under IVDR for EU customers.
At TTP we bring together world-leading scientists and engineers to deliver cutting-edge diagnostics solutions today. We have a proven track record of working at the forefront of technology, inventing disruptive diagnostic systems every day. We integrate complex processes into easy-to-use and low-cost disposables. We offer clients complementary technologies that ensure they can deliver. We are unrivalled in speed of development, confidence of functionality and of regulatory manufacturability. Delivering diagnostics solutions of the future today.
Health is a leader in digital pathology, providing award-winning solutions to healthcare providers worldwide. Focused on meeting the growing demand from hospitals and laboratories to transition from traditional analogue (glass slide) pathology to a complete digital solution, Tribun Health is committed to innovation and excellence. Our mission is to empower customers to improve productivity, efficiency and diagnostic accuracy in their practice.
TNO is a research and technology innovation institute which drives biomedical, technological and social innovations in collaboration with knowledge institutes, industrial partners and government authorities. Multidisciplinary teams of top scientists and technical experts enable us to model, mimic and measure infant health and disease risk. We connect experimental and clinical studies with innovative technologies to identify new biomarkers for health and disease, as well as substantiate the health benefit of compounds. Together, we can make a contribution to future health.
TissueGnostics provides streamlined solutions for both imaging and image analysis. The goal of TG is to bring the same type of phenotypical analysis of single cells from Flow Cytometry into tissue context. The merging of image analysis software and high-quality optics and robotics has allowed TG to create the TissueFAXS system – a fully automated system which can scan slides/well plates and automatically quantify marker expression per cell.
Thermo Fisher Scientific supports developers and manufacturers of biological-based products with a world-class product portfolio that spans the bioprocessing workflow from discovery through large-scale commercial production. We provide solutions across the manufacturing value stream, including comprehensive measurement and control solutions such as Raman in line process analyzers, and handheld technologies: NIR, Raman, and XRF, for raw material identification.
.jpg)
The Phytobiomes Alliance is an international, non-profit consortium of industry, academic, and governmental scientist. The goal of the Alliance is to establish a science and technology foundation for site-specific, phytobiome-based enhancement of sustainable food, feed, and fiber production.
The Pathologist is a leading publication for professionals in the fields of pathology and laboratory medicine. Through its many resources – website, newsletters, webinars, social channels, monthly print magazine and videos – The Pathologist gives its vast audience of readers a truly global and multimedia platform from which to learn, communicate, network and further the field of diagnostic medicine.
The Medicine Maker is a new publication focusing on manufacturing and development in the pharmaceutical and biopharmaceutical industry. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to integrate all aspects of the process, from clinical research through to commercial-scale production. The Medicine Maker combines topical news coverage with practical, pragmatic articles that are meaningful to the daily working life of experts in the regulatory, development and manufacturing fields. Feature articles tell the stories behind the biggest concepts, issues and advances in the field, covering business, policy and career development.
Techcyte is the most advanced Clinical Pathology AI platform for bodily fluids, with deep learning image analysis solutions for fecal ova & parasite detection, cervical cancer screening, automated blood differential, bacteriology BV gram stain analysis and digital manual review of other sample types, bladder cancer detection, and remote pathology for digital FNA consultation. Techcyte enables labs to lower costs, improve accuracy and deliver quicker results to patients.
Symcel provides a novel cell-based assay tool for real-time biological activity measurements using isothermal microcalorimetry. Our solution, the calScreener™, delivers a phenotypic, metabolic readout in real-time. By directly measuring the heat produced that result from metabolic processes in the sample, you get an energy output measured in μW, providing new insight, not previously possible with traditional methods. Measurements are sample independent, simply place your sample in the calScreener™ and let it do the rest.
Stratipath is an AI company dedicated to revolutionising cancer treatment decisions. Stratipath’s pioneering solution, Stratipath Breast, is the first EU- and UK-regulatory-compliant solution for prognostic risk profiling of breast cancer using AI-based analysis of H&E images. Stratipath Breast is currently in clinical use and is considered a faster, more cost-effective alternative to molecular assays. By using Stratipath Breast, clinicians can diagnose with the support of prognostic information, while reducing laboratory time and costs.
Standard BioTools Inc. equips the life science industry with a unique suite of innovative and reliable multi-omic technologies that enable researchers to boldly explore life sciences challenges that advance human health.
SPD Scientific offers a comprehensive range of top-notch laboratory consumables, test-kits reagents, biomedical and laboratory equipment, and a host of microbiology culture media and diagnostic products. The company offers myriad benefits to customers in wide ranging industries, such as F&B sector, pharmaceutical, academic and government research institutions, and healthcare, by providing them the essential tools to assist in their medical research and discoveries.
Source LDPath, a part of Source BioScience, helps pathology labs go digital with its ground-breaking modular digital pathology and AI pathway which helps transform diagnostic processes by drastically decreasing turnaround times from sample receipt to result, to help patients access appropriate treatment as quickly as possible. We are your guiding hand in digital pathology and AI integration.
SomaLogic is catalyzing drug research and development and biomarker identification as a global leader in proteomics technology. With a 55 microliter plasma or serum sample, SomaLogic can run 11,000 protein measurements, covering more than a third of the approximately 20,000 proteins in the human body.
Solis Agrosciences has launched the world’s first Plant Pipeline as a Service (PPaaS™), an integrated, end-to-end pipeline for the design, production, and characterization of gene-edited and transgenic plants. This fee-for-service model allows our clients to retain intellectual property rights. Our full-service offerings include gene cloning, gene editing, plant transformation, plant growth, and various molecular, biochemical and physiological assays. Our team of experienced scientists, entrepreneurs, and AgTech leaders are here to support your research needs.
Smaltis is a private laboratory specialized in microbiology and molecular biology, delivering tailor-made in vitro solutions to support the development of health products, from research to clinical trials. One of the fields of expertise is microbiota harnessing with the support of microbiome-based programs for health prevention and therapeutic benefits, thanks to strain characterization and optimization, mechanism of action assessment and monitoring during (pre)clinical phases. Smaltis also works on the fields of antimicrobial resistance, bioproduction and genomics/transcriptomics.
Singlab Technologies is a specialist distributor of instruments, research standards and services to Singapore Life Science, Biotech and Biomedical Industry. We offer a variety of products and services, including antibodies, proteins, ELISA kits, molecular biology reagents, and custom services. These products and services are used by researchers and clinicians to better understand the mechanisms of diseases, develop new therapeutics and diagnostics, and improve patient outcomes
With over 30 years of innovation and more than 2,000 installations around the globe, Sectra is a leading imaging IT provider to health systems worldwide. Sectra offers a complete enterprise solution comprised of imaging modules (radiology, cardiology, pathology, orthopaedics, and ophthalmology) and a robust VNA. Over the last 10 consecutive years, Sectra has been awarded Best in KLAS for the highest customer satisfaction. For more information, visit Sectra’s website.
SCC Soft Computer is a leading LIS vendor at the forefront of laboratory, genetics, outreach, and blood services software development. Committed to supplying innovative technologies to meet the needs of every client, SCC offers comprehensive suites of fully integrated, Web-enabled laboratory and genetic information management system solutions. The world’s largest LIS production house, SCC Soft Computer has designed, developed, delivered, implemented, and supported robust clinical information management system solutions for the healthcare industry since 1979.
At SalamanderU, we help you to win time, to reduce COG and to be cGMP compliant by providing : Expertise in ATMP and pharma regulation (QP and Bio engineer onboard!), Customized and evolutive isolators in Acrylic resin ( easier to clean and more robust against H2O2). – A unique (patented) electronic Batch Records guided by voice
RareCyte provides Precision Biology™ products and services for discovery, translational research and clinical diagnostics. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings enable CTC and other rare cell characterization and single cell retrieval for molecular analysis and CDx development.
rapidmicrobiology.com is a well-established on-line resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions. Keep up-to-date with the latest microbiology news by getting our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.
For 40+ years, QuickSTAT has been providing the leading pharma and biotech companies 24/7 global life science logistics solutions, from R&D, and clinical trials through to commercialization. Our logistics experts provide time-and temperature-sensitive transport of clinical research samples, cell and gene therapies, investigational drugs, clinical trial supplies and vaccines. Chain of custody/identity, and GDP protocols ensure product integrity and patient safety. Consultation and procurement of proper packaging—from controlled room temperature to cryofrozen.
QIAGEN serves more than 500,000 customers globally, all seeking insights from DNA, RNA and proteins – the building blocks of life. Using any biological sample – be it blood, a throat swab or many other materials – we help our customers advance science and improve outcomes for people everywhere. Our products for molecular research and testing serve a wide range of applications from basic life sciences research to clinical healthcare. Together, we are making improvements in life possible.
Proscia is elevating the role of pathology in advancing precision medicine to improve patient outcomes. We believe that pathology data holds the keys to reshaping the way drugs are developed, diseases like cancer are diagnosed, and patients are treated. We’re unlocking the full potential of this data with our digital pathology software, Concentriq.
Founded in 1985, Probiotical stems from the Mogna family’s 60-year expertise in lactic acid bacteria production in Novara, Italy. Beginning with Alfonso Mogna in the 1920s, the family revolutionized dairy fermentation through innovations by Mario Mogna. Giovanni Mogna later expanded into probiotics for human health. Now led by fourth-generation CEO Vera Mogna, Probiotical excels in research, manufacturing, and service, becoming a leader in Italian and international probiotic markets, exploring the human microbiome’s role in health.
Based in Cambridge, MA, Pramana, Inc. pioneers digital pathology advancements through cutting-edge whole slide imaging (WSI) systems. Driven by patented technology, our solutions redefine industry standards, delivering superior image quality and streamlining workflows while minimizing manual intervention. In doing so we empower pathologists, automate labs, and enable the next generation of algorithm development. Pramana is committed to advancing digital pathology through innovation, automation, and flexible business models to meet the vast needs of pathology practitioners
Plants is an open access journal that covers all key areas of plant science, supported by an outstanding Editorial Board composed of high-profile researchers (https://www.mdpi.com/journal/plants/editors). Currently, /Plants/ is indexed by many important databases, including Science Citation Index Expanded (SCIE), PubMed, and Scopus
At PathPixel, we offer a wide range of resources to help accelerate the digital pathology transformation in your laboratory. Our website provides access to various technologies and tools that are needed for successful implementation, including image analysis software, digital slide scanners, storage solutions, and much more.
Paige is using the power of AI to drive a new era of cancer discovery and treatment. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology and built the largest million-slide Foundation Model for cancer. This same technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options.
Pacifi’s DuoVIAL® pharmaceutical packaging technology is designed to Protect, Mix & Deliver, your topical (LBP) probiotic strains, for skin-microbiome therapies.
Our DuoDERM Applicator System is reusable, whilst incorporating single-use, glass cartridges to enhance your product shelf-life, protecting lyophilised formulations from degradation.
Easy reconstitution within the dual-chamber cartridge is achieved simply by a twist of the cap to activate.
Apply topically through a range of applicator options.
Visit our booth to discuss!
Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by breath-based diagnostics, through the development and application of Breath Biopsy®. Breath Biopsy operates by detecting volatile organic compounds (VOCs) produced as the end product of metabolic processes within the body or from external sources such as the microbiome, diet or medication, changes in which can be characteristic of specific conditions and diseases.
Owkin is the first end-to-end AI biotech on a mission to understand complex biology and ensure every patient gets the right treatment. We use cutting-edge causal AI to identify precision therapeutics, de-risk and accelerate clinical trials and develop diagnostics. We merge wet lab experiments with advanced AI techniques to create a powerful feedback loop for accelerated discovery and innovation in oncology, cardiovascular, immunity and inflammation. Owkin also founded MOSAIC, the world’s largest spatial multi-omics atlas for cancer research across seven cancer indications. Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like F-Prime, GV and Bpifrance, among others.
OracleBio is a global leader in quantitative digital pathology, providing image analysis services to Pharma and Biotech clients worldwide. We support Pharmaceutical R&D with detailed quantification of Histopathology images, transforming research possibilities and harnessing cutting-edge technology such as AI and Deep Learning to enhance our workflow.
Objective Imaging’s Glissando slide scanners offer exceptional image quality, flexibility, and reliability, supporting both standard and mega slides, with options for brightfield and polarised light scanning. Our new Glissando XL+ slide scanning solution controls multiple Glissando scanners from a single interface. With parallel scanning to increase throughput and redundancy to ensure maximum up-time, the Glissando XL+ scales to meet your scanning capacity requirements, from a few dozen to several hundred slides per day.
Nutrition Insight is the leading source for the latest news on health and nutrition, sustainability and the global nutraceutical market.
Nutrition Insight is published by CNS Media, a leading global B2B publisher of FMCG industry news and market analyses whose brand portfolio brings reliable, independent journalism from food manufacturing, health and nutrition, packaging technology and beauty and personal care.
Their free daily newsletter services provide actionable insights that help navigate opportunities and keep you at the forefront of this fast-evolving industry.
Nutrients (IF: 6.706, ISSN 2072-6643) is an on-line open access journal that was first published in 2009. Nutrients adheres to rigorous peer review and editorial processes and publishes only high quality manuscripts that address important issues related to the impacts of nutrients on human health.
The National Pathology Imaging Cooperative (NPIC), is funded by the UK Industry Strategy Challenge Fund. NPIC is driving digital pathology adoption in the NHS through a collaborative effort involving the NHS, academia, and industry partners. With over £60m in public and industry funding, NPIC deploys digital pathology systems in hospitals across the country, disseminating best practice to support the development and evaluation of AI to improve pathology services and patient outcomes.
Novogene is a leading provider of genomic services and solutions with cutting-edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. As the largest NGS service provider, Novogene has branches in the US, UK, Germany, Singapore, Netherlands, China, and Japan. Novogene was founded in 2011 and has been growing rapidly over the past few years, and has genomic sequencing labs in the US, the UK, Germany, China, Singapore, and Omics CORE in Japan.
NemaLife is a techbio platform company developing sustainable AI-powered microfluidics solutions to discover and develop safe and efficacious ingredients. Its patented organism-on-chip platform de-risks and accelerates product development in several industries, including functional foods, sports nutrition, dietary supplements, and animal/pet nutrition. NemaLife Inc. partners with other innovative companies and academic institutions to discover and develop novel functional ingredients that can sustainably improve the quality of life.
NCBiotech was built on the recognized value of NC’s life sciences and the ag tech sector is a cornerstone of the state’s leadership as a global life science hub. The ag tech ecosystem is a prime example of the state’s tradition in agriculture advancing through innovation to create unmatched research and business opportunities. NCBiotech, in support of NC as an international ag tech hub, is focused on further stimulating growth through programs, funding, and collaboration with key stakeholders and the NC Ag Tech Council. Together the commitment to drive impacts that accelerate technology based economic development through innovation, commercialization, education, investment, and job creation are unparalleled.
NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions. The GeoMx® Digital Spatial Profiler combines the power of whole tissue imaging with gene expression and protein data. The CosMx™ Spatial Molecular Imager is an FFPE-compatible, single-cell imaging platform powered by spatial multiomics. The AtoMx™ Spatial Informatics Platform is a cloud-based informatics solution.
mTuitive is at the forefront of shaping the future of reporting, data, and analytical software for digital pathology and surgical oncology. Historically, when medical record data is dictated and transcribed, it gets stuck. When a single patient’s data can be aggregated with the results of a thousand different reports, the patient benefits because the entire standard of care is elevated. In addition, hospitals and surgery centers can effectively capture all required data and ensure standards compliance. As the originator of synoptic reporting software, mTuitive continues to lead the industry with continuous innovation, enabling the best minds in medicine to discover new insights and understanding.
Mirxes is a Singapore headquartered biotechnology company focused on development and commercialization of RNA centric genomic technologies and novel molecular diagnostic tests for disease early detection and precision medicine. We have built significant vertical capabilities in genomic and clinical biomarker research, in vitro diagnostics test development and manufacturing, and molecular focused clinical testing services.
For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell analysis needs. Our Spatial Biology solutions include ultrahigh-plexed immunofluorescence and 3D light sheet imaging to support research applications for immunology, stem cell biology, neuroscience, and cancer.
Mikroscan’s vision is that every patient will receive the right diagnosis from the right expert at the right time, regardless of where they live in the world. We provide high-quality telemicroscopy and digital pathology systems that increase efficiencies for busy pathologists and provide decision support for more accurate diagnosis.
With our solutions, pathologists improve patient care with faster and more accurate results; generate more revenue by providing subspecialty expertise to rural or remote areas; and save travel time, improve turnaround time, and save money.
Metabolon deciphers thousands of discrete chemical signals from genetic and non-genetic factors to reveal biological pathways. We make connections where other omics cannot, and provide the definitive representation of the phenotype. Our scalable, customizable metabolomics solutions provide support across the research continuum from discovery through clinical trials, to in-market life cycle management.
Medica has 20 years of experience in supporting the NHS with diagnostics. Our pathologist-led, fully digitised, histopathology reporting and scanning service has flexible options to help you address your backlogs, provide additional capacity and offers access to sub-specialist expertise. We can provide a high-quality service, with fast turn-around times and a resilient clinical governance structure. Not already digital? We can digitise slides for you. Find out more at the Digital Pathology and AI Congress Europe.
Lunaphore Technologies – a Bio-Techne brand, is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology that can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies.
Lumito specializes in digital pathology medical technology, aiming to enhance tissue diagnostics with its patented technology. Using upconverted nanoparticles (UCNPs), high-quality images with improved contrast and reduced background information are generated. These images shorten analysis time and provide higher-quality images. Lumito, a spinoff from a research group at Lund University’s Department of Atomic Physics and Laser Center, plans to launch its product, SCIZYS, for research laboratories initially.
Lumea, a forefront innovator in digital pathology, places patients at the core of its approach. Their best-in-class tissue-handling technology and integrated workflow AI ensure standardization and optimal tissue integrity throughout the entire pathology ecosystem, enhancing overall efficiency and quality. This distinctive strategy improves tissue yield and quality, which can lead to higher cancer detection rates, and results in a return on investment in cost and time-sensitive environments, ultimately setting a higher standard for patient care in cancer diagnostics. Learn more at www.lumeadigital.com.
Leica Biosystems (LeicaBiosystems.com) is a global leader in cancer diagnostics with the most comprehensive portfolio from biopsy to diagnosis.
Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture.
Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
Leading Probiotics Forward. With 90 years of know-how, we specialize in the development, production and marketing of probiotics for human health. Our R&D center, the Rosell Institute for Microbiome and Probiotics, develops partnerships with key scientific experts to study the human microbiome and probiotic supplements to improve or maintain health in specific populations or health segments. Our CDMO capabilities, Expert’Biome by Lallemand, leverage all assets to create the next generation of probiotics and live biotherapeutics.
Julius Clinical is a global Academic CRO with a distinct focus on unmet medical needs. Our scientific expertise combined with creative operational solutions uniquely equips us to assist in providing answers for today’s clinical drug development challenges. As a response to the NASH conundrum, we initiated: GRIP ON NASH, a multinational research initiative in which 10,000 patients at risk will be screened for the presence of NAFLD and NASH.
INFINITT is a pioneer among global PACS manufacturers. More than 6,500 customers in over 55 countries use INFINITT’s products.
The innovative product portfolio ranges from INFINITT PACS as a cross-departmental solution for image data management and INFINITT Healthcare Platform as a Vendor Neutral Archive (VNA). INFINITT’s digital pathology solution simplifies the entire pathology workflow and enables more efficient, accurate and faster diagnosis and reporting. The products are complemented by AI applications for data analysis.
At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy DNA and RNA sequence data in studies around the globe. The innovative products that we provide are helping drive advancements in a multiomic understanding of cellular functions, combining transcriptomics, epigenetics, and proteomics. Multiomics profiling studies enable a more comprehensive understanding of development, cellular response, and disease, fueling the discovery of novel drug targets and biomarkers. The progress our customers have made and what lies ahead inspire us to push the boundaries of what is possible so we can create the next generation of genomics solutions.
ICON Outlook Magazine is a hub for businesses around the world using technology to transform our world. Our seasoned researchers, analysts, and writers spot global trends and the latest tech marvels poised for disruption. As a team with the most powerful and futuristic vision, we cater to the largest community of tech buyers, users, and enthusiasts around the globe. We demystify the industry space, enabling businesses to modernize and grow by creating their own niche of innovation.
Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology.
We use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist.
The Ibex platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers eliminate diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity.
Deployed worldwide, it is the first-ever AI-powered cancer diagnostics platform used in routine clinical practice in pathology labs, with demonstrated success in improving the quality and efficiency of cancer diagnosis.
I. Miller Microscopes is a family owned and operated microscope sales & service business, now in its 4th generation. Founded in 1936, we have been serving the educational, industrial and clinical microscope markets for over 80 years.
Huron Digital Pathology – We are on a mission to transform glass biopsy slides into shareable knowledge. Our Scan, Organize, and Analyze solution for pathology combines award-winning whole slide scanners with powerful image search technology integrated into management systems to connect pathologists, researchers and educators with the expertise of their colleagues to help speed up diagnosis and accelerate disease research.
.jpg){kind=logo}
HistoWiz automates histopathology with rapid turnaround time for researchers in academia, biotech and pharma. The company processes tissue specimens and digitizes the results, hosting client’s data on a proprietary platform, PathologyMap. The online platform hosts one of the largest collections of preclinical data in the world and allows researchers the ability to instantly view, manage, analyze, and share their digital slides in seconds.
GuangDong Handsome Bio-Technology Co.,Ltd., Focus on freeze-dried skincare products, has experienced in the functional skincare for 15 years. A manufacturer, we do skincare products OEM/ODM as well as own branding with a focus on innovative design, advanced research and and fine manufacturing of freeze-dried powder skincare products.
Hamamatsu Photonics is a world-leading manufacturer of optoelectronic components and systems. The Company’s corporate philosophy stresses the advancement of photonics through extensive research and yields products that are regarded as state-of-the-art. Hamamatsu has over 15 years of real-world experience in delivering sophisticated whole slide imaging (WSI) solutions across the globe. Our NanoZoomer whole slide scanner series quickly transform entire histology and cytology glass slides into diagnostic-quality digital images for duplication, annotation, storage, retrieval, and image sharing.
Gestalt Diagnostics transforms pathology through an intelligent, configurable, vendor-neutral, and AI-driven digital workflow that provides true interoperability enabling pathologists to diagnose* diseases faster and more efficiently. Our PathFlow solution consists of professional, education, and research modules for ease of mixing and matching the digital needs of your facility in a single solution, freeing pathologists from tedious, repetitive, and manual tasks, allowing them to focus on their expertise – providing invaluable experience where it matters most.
At Gaia Science, our experienced team excels in providing cutting-edge digital pathology and histopathology solutions in imaging, tissue analysis, data management, deep learning AI models, cloud-based image analysis applications and more, for hospitals, pharma, biotech, CROs, and academic researchers.
Being a market leader, we aim to bridge state-of-the-art technologies to you in your pursuit for discovery and automation.
Our comprehensive portfolio also includes laboratory equipment and services, supporting all disciplines of scientific research.
Fujifilm Healthcare UK Ltd is a leading provider of innovative medical imaging systems and healthcare solutions. Our portfolio covers digital x-ray, mammography, ultrasound, CT, MRI, enterprise imaging solutions (including PACS, VNA, Clinical Workflow Management and 3D surgical planning tools), AI, Digital Pathology and near patient IVD testing analysers for dry chemistry.
With a history of manufacturing x-ray film since the 1930s, for decades we have been using our heritage in photography and film to bring exciting new solutions to the healthcare market. By leveraging advanced technology from across a broad business, we have developed new ways of meeting the needs of modern healthcare by providing value through innovation.
Food & Function provides a unique venue for physicists, chemists, biochemists, nutritionists and other food scientists to publish novel, cutting-edge, original research focussing on food, its nutrients and their relation to human health and nutrition.
Sierra® technology from FFEI standardises colour for digital pathology scanners and scanner-agnostic AI applications.
The Sierra Slide with VS-Profiler software measures and calibrates to the real ground-truth colour of histopathology. Standardisation of digital colour to the validity of real glass slides delivers quality assurance for pathologists and AI.
Established in 1947, FFEI has a reputation for developing award-winning, innovative life science imaging solutions.
Evident Life Science (former Olympus Scientific Solutions) empowers scientists and researchers through collaboration and cutting-edge life science solutions. Dedicated to meeting the challenges and supporting the evolving needs of its customers, Evident Life Science advances a comprehensive range of clinical, research, educational, and premium microscopes and microscope systems.
Eurofins Genomics – Supporting agrigenomics challenges
We offer a portfolio of testing solutions to support the work of animal, companion animal breeders, plant and aquaculture breeders including:
ESI Ultrapure is the Life Science division of ESI Technologies Group. We provide quality products and solutions for the bio-pharmaceutical industry in Ireland and the UK. We have built a comprehensive Life Science portfolio with global manufacturers. We have ISO Class 7 cleanrooms in our Irish facility which specialise in custom single use assemblies. Efficiency and quality are priority in ESI, from turnaround times, design flexibility, suitability of application, whilst ensuring the highest quality standards.
Eremid® Genomic Services is a high complexity CLIA-certified genomics contract research organization, with world-class scientific staff, and cutting-edge genomic instrumentation and automation to create a unique offering to meet the increasing demands for higher data quality, reliability, and accuracy in genomics research.
At the heart of successful pathology labs.
Epredia, powered by passionate people, offers solutions that give you increased control over your total anatomical pathology workflow. Providing end-to-end solutions, Epredia offers a diverse range of instruments and consumables that continue to transform the histology and digital pathology market and improve patient outcomes.
With over 85 years supporting anatomical pathology and world class service, customers put their trust in Epredia over a billion times every year. Every second of every hour of every day, 44 of our products are employed in the battle against cancer.
EIZO means image in Japanese. Founded in 1968, we develop and manufacture high-end visual solutions to meet the specialised needs of customers in healthcare, business, creative fields, air traffic control, maritime, security & surveillance, and more. While the customers we serve are many, our mission is always the same – to create total imaging solutions that enrich people in their professional and personal lives.
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health.
FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 4 200+ peer-reviewed publications and 180+ international guidelines.
Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide.
Don Whitley Scientific has designed and manufactured workstations for over 40 years. Use a Whitley Workstation in your research – the proven way to emulate the anaerobic conditions of the intestinal microenvironment. Call at the Don Whitley Scientific stand and see how our workstations have been developed specifically for researchers. There is a comprehensive range of features to help replicate an in vivo environment, plus options and accessories to tailor the workstation to meet your requirements.
Diagnexia connects hospitals worldwide with top subspecialty pathologists through digital pathology, ensuring high-quality care and fast diagnostics. Referring laboratories can directly enter cases into our system, where they are assigned to the best pathologists, delivering reports online. Services include primary reporting via accredited labs, secondary consultations on complex cases, and quality assurance, providing expert feedback on diagnostic and technical quality. Diagnexia supports diverse client workflows, including leveraging existing scanners, leasing scanners, and receiving client materials.
Dell Technologies provides transformative solutions that help healthcare-life sciences organizations prepare for the road ahead as they accelerate their digital strategies – from the point of care to the core to the cloud. From the world’s leading healthcare systems to rural health clinics, we offer essential infrastructure solutions for Modernized Technology, Connected Workforce, Virtual Health, Personalized Health and Secure Care to help you achieve business and clinical agility.
Deep Bio Inc. pioneers AI-driven oncology solutions with advanced In Vitro Diagnostic Software as Medical Devices (IVD SaMDs). Our flagship product, DeepDx Prostate, delivers accurate and standardized Gleason scoring and tumor quantification, revolutionizing prostate cancer diagnosis and treatment. By driving innovation, we empower clinicians with actionable data-driven insights, transforming patient care and advancing the field of precision oncology.
Dedalus is the leading healthcare and diagnostic software solutions provider in Europe, and one of the largest in the world, with over 30 years of experience in implementing successful laboratory solutions in over 5700 laboratories worldwide. Dedalus solutions enable the seamless full digitalization of the Anatomic Pathology workflow, from the tissue reception to the digital reporting, leveraging AI to accelerate the shift towards precision medicine and patient-centered solutions.
Curiosis Inc, is a company that develops, produces, and supplies laboratory equipment in the field of life science. We provide solution for improving the efficiency of cell-based research processes and endeavor to become a leading company in the bioindustry. Based on our core technologies in mechanical engineering, biophysics, and electrical engineering, we aim to provide high-quality products to our customers as well as contribute towards a better future for humanity.
CureDiab is a spin-off from the German Diabetes Center, was established in 2021, and has obtained seed financing. The company operates research labs and develops a first-in-class approach for MASH therapy using novel modulators of the GABA-A receptor. Hepatoprotective and anti-fibrotic activity of the patented lead compounds HK1,3 has been demonstrated, with a dual action on both hepatocytes and stellate cells.
Cryptobiotix is a preclinical CRO providing insights into gastrointestinal processes and the gut microbiome. The validated ex vivo SIFR® technology combines unmatched throughput and predictivity for clinical outcomes. We offer research services to customers in the area of functional foods and therapeutic products, across foodtech, biotech and pharma. From early R&D screening to in-depth characterisation, we address specific research questions and provide customers with the answers needed to accelerate and de-risk their product development.
CosmosID® provides end-to-end solutions unlocking the microbiome. A provider of CLIA-certified & ICH-GCP compliant NGS, Metabolomics and Bioinformatics Solutions, CosmosID offers a range of validated and optimized workflows for research and development. CosmosID also offers independently validated, industry-leading pipelines for processing metagenomic data, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision. Results can be accessed via CosmosID-HUB, a user-friendly and interactive software for comparative analysis of microbiome data, complete with dynamic charts, visualizations, and statistics.
COSMAX Group is a global no.1 research, development and production business group for cosmetic and health functional food products. Today, one quarter of the world’s 7 billion population use COSMAX. beauty products. Across the globe, 600 beauty companies, including 15 of the world’s top 20 beauty companies, are in a partnership with COSMAX. COSMAX Group, built around the global leader of K-Beauty, COSMAX, consists of COSMAX NBT and COSMAX BIO, companies specialized in the production of health functional foods and medical supplies. As a cosmetics manufacturer, and a company that develops and manufactures equipment as well as special packaging, we are interwoven and focused through each field and integration.
Corista’s DP3® delivers an extensive toolkit supporting Clinical, Research and Education applications in a rich, collaborative environment.
From a single whole-slide image, DP3’s suite of interoperable pathology workflows and image management tools enables pathologists and scientists to better analyze, collaborate, teach and report their findings across, and between organizations. DP3 integrates major whole slide image scanning systems, image analytics and LIS/EHR platforms for clinical and research organizations. Health Canada and CE-Mark cleared.
Computomics offers a proprietary machine learning technology platform that applies AI to genetics, phenotype, microbiome, and environmental datasets. Computomics is a team of world-leading experts in machine learning, plant research and bioinformatics, who use data to unlock the diversity of biological life. Our interpretable machine learning technology enables rapid understanding of genomic data for plant breeding, agricultural biotech, and microbiome researchers. To learn more about Computomics, please visit computomics.com or follow Computomics on Twitter at twitter.com/Computomics.
Clinisys is a global provider of intelligent diagnostic informatics solutions and expertise designed to redefine the modern laboratory, across healthcare, life sciences, and public health. Millions of diagnostic results and data insights are generated every day using Clinisys’ platform and cloud-based solutions in over 4,000 laboratories across 39 countries. Clinisys’ mission is to enhance the effectiveness of diagnostic workflows in any laboratory or testing environment and keep citizens and communities healthier and safer.
Clinical Microbiomics is a CRO dedicated to microbiome science from discovery through to clinical validation. We offer advanced clinical trial and R&D programs with end-to-end microbiome and metabolomics services, including multi-omics integrative data analysis and machine learning. Complemented by the highest resolution microbiome profiling available, our advanced bioinformatics enables clonal-level resolution, strain tracking and engraftment analysis for microbial therapeutics including FMTs, LBPs and probiotics. In addition, observed engraftments can be correlated with clinical outcomes and used for strain selection and MOA hypothesis generation. With extensive experience in analysing samples for clinical trials, our regulatory experts partner with you to provide a submission-ready data package, facilitating the use of microbiome endpoints in clinical trials. Furthermore, we support infant nutrition companies in understanding HMO utilisation and development of the infant gut microbiome from birth to early childhood, with a range of infant microbiome focused annotations and AI tools.
Cirdan offers next generation, cloud-based, scalable Laboratory Information System, with seamless integration of digital pathology and AI, that help labs automate and manage their core workflows and clinical pathways for optimal performance and quicker patient diagnosis. Cirdan equips laboratory pathologists and scientists with powerful deep-learning tools to advance their analysis, improve workflow efficiency, collaborate remotely, make exciting discoveries from their data, and ultimately provide better patient treatment pathways.
ChemoMetec specializes in developing and producing high-precision instrumentation that delivers consistent data for thousands of customers across segments, including bioprocessing and pharma. Our NucleoCounter® instruments are the most robust and consistent cell counters on the market. They are standardized for easy deployment across departments and are 21 CFR Part 11-ready. Designed, manufactured, and tested in Denmark, we build our instruments and consumables with quality materials and dedicated expert workmanship.
Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools to the biomedical research community. Our employees operate worldwide from our U.S. headquarters in Massachusetts, and our offices in the Netherlands, China, and Japan.
Canopy Biosciences®, a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. We offer instruments and services for spatial proteomics and transcriptomics, providing a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction. Learn more by visiting CanopyBiosciences.com.
Biose Industrie is the world leading CDMO for Live Biotherapeutics and Next Generation Probiotics. A one stop shop for your Product with Process Development, Scale-up, Drug Substance and Drug Product manufacturing at GMP Pharma, Food supplement and Cosmetic level for Oral, vaginal and topical delivery.
Over 500 different strains manufactured in high volumes over 70% of which are strictly anaerobic bacteria.
Utilizing their qPCR-based Precision Microbiome Profiling (PMP™) platform, Bio-Me is transforming microbiome analysis, making it possible to analyze hundreds of samples in less than a day, with high resolution and reproducibility, at an affordable cost. With the existing range of PMP™ panels, Bio-Me offers profiling of fecal, skin and vaginal microbiome samples. Bio-Me also supports microbiome therapeutic companies during their clinical development programs, by providing Companion or Complementary diagnostic tests with clinical applicability.
Biobased Press is an independent, non-sponsored website that takes a helicopter view of the biobased economy. It discusses business and research, and links the biobased economy to neighbouring areas like sustainability, biotechnology, energy, agriculture, policy and the economy. Recently, we ran a series on the history of antibiotics.
.jpg)
Bilfinger Life Science designs and builds process equipment and piping for the pharmaceutical, nutrition and environmental market segments. As an experienced design-build-run partner, we provide a wide range of services: from consulting, engineering and process development through fabrication, automation, installation and commissioning of equipment to documentation, qualification and maintenance. Our clients benefit from an optimized single-source full-service solution eliminating interface losses, providing clear responsibilities as well as highly efficient supplier management.
Beckman Coulter Life Sciences is known for technologies that simplify and automate biomedical research. Our mission is to empower those who are seeking answers to life’s important scientific and healthcare questions. This mission embodies our efforts to help you get the data and answers you need, when you need them.
BaseClear is a biotechnology company with strong expertise and experience in applied microbiology. With our state-of-the art robotics and analysis equipment, including the latest sequencing technologies such as Illumina and Oxford Nanopore Technologies we offer a complete suite of microbial genomics services from metagenomics, microbiome analysis to microbial strain characterization services and culturomics. Being the preferred partner for many leading brands in various industries such as food, food ingredients, pharma, personal care, and animal health in the Netherlands, in Europe and beyond, we support our clients in improving their processes and products, gaining approval and confirming claims.
The more we uncover about the microbial world, the more we realise there’s much more to discover. We are on the verge of truly understanding the role of microbes in health, disease, nutrition, and the environment. BaseClear is actively cooperating with other experts to identify, characterise and analyse many novel microbial strains for a wide range of applications to further accelerate our understanding and use of microorganisms for a more sustainable, safer and healthier future.
Barco is a technology company specialized in visualization and collaboration solutions for healthcare, enterprises and entertainment.
We connect healthcare professionals at almost every patient touch point, from the imaging room, to radiology, through specialist consultations and in the surgical suite. By providing medical staff with the complete and most accurate picture, we enable more informed decisions, when and where it matters most.
YOUR VISION. OUR INSPIRATION
Shaping a future with better patient outcomes requires adopting new technologies in hospitals and laboratories – which in turn can challenge traditional workflows.
At Axlab, we help you achieve better outcomes by optimizing your laboratory workflow. With us, you get validated advanced instruments, unique quality consumables, end-to-end services and support, plus education and certification through Axlab Academy.
No matter your needs, our dedicated team can help you shape better best practices meeting future demands: your vision is our inspiration.
Avalo is a biology company that harnesses interpretable machine learning and evolutionary theory to rapidly design new crops for the future of agriculture. Avalo uses AI-assisted natural breeding, not genetic modification, to support and leverage the natural diversity of the world around us. The technological core of Avalo is a discovery engine that can identify the basis complex traits with minimal training. Avalo uses these findings to reduce crop development time by years and cost by an order of magnitude.
Aurora mScope is a vendor-neutral image management, case management, workflow, and reporting platform which allows hospitals and clinics to utilize scanners and AI from multiple companies. The platform includes a full-featured viewer with annotation and measurement tools, which is highly responsive, even over slow networks. Aurora mScope makes it easy to request consultations, and to present material at tumor boards and for educational purposes. The system can be deployed either on-premises or in the cloud.
Atlantia Clinical Trials is the world-leading microbiome CRO. For over a decade they have delivered clinical results to nutraceutical, cosmetic and pharma companies around the world. They strive to offer the highest quality science while maintaining a cost-conscious approach to maximise the value proposition.
Their state-of-the-art clinic sites both in Ireland and the USA ensure they can offer multicentre multinational studies of all design types, across a broad and diverse array of health areas and product portfolios.
Aspect Analytics develops software for analyzing and integrating spatial omics data. The company offers platform solutions for data management, bioinformatics and reporting, along with joint research and custom development services. Aspect Analytics bridges the gap between bioinformatics research and enterprise-grade software platforms to support key spatial omics applications. The software can (i) extract maximal knowledge from spatial data, including co-registering different modalities, (ii) scaling for high-throughput, and (iii) providing integrated data management, traceability and more.
The ASEPTIC GROUP is specialised in Biopharm fluid transfers. An independent integrator in single-use systems dedicated to bioproduction, we are the specialist in sterile fluid transfer solutions in critical environments. Our 2 complementary activities make us an experienced partner that is recognised in the market, notably: Proven expertise for more than 20 years in marketing single-use components suited to a wide range of applications The design and production of custom single-use assemblies, ready for use in ISO Class 7 in activity clean room Our total independence enables us to guarantee you the right solution for your needs.
Anaerobe Systems has over 40 years of experience specializing in manufacturing pre-reduced anaerobic culture media, anaerobic transport media, and anaerobic chambers for the cultivation and transport of anaerobic organisms. We specialize in producing customized media formulations to meet our customer’s unique requirements and have a range of standard products that support the growth of human microbiota. Anaerobe Systems manufactures and sells anaerobic chambers which provide an oxygen free environment for manipulation and growth of anaerobic organisms.
Akoya Biosciences offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode™ Panels and PhenoCycler®, PhenoImager® Fusion, and PhenoImager HT Instruments.
AIRA Matrix provides Artificial Intelligence solutions for Life Science applications. Our products and services improve efficiency, diagnostic accuracy, and turnaround times in pathology laboratory workflows.
Our diagnostic, prognostic, and predictive solutions for cancer care aid disease stratification and enable management protocols tailored to improve treatment outcomes.
Aiforia equips pathologists and scientists in clinical, pre-clinical, and academic labs with powerful deep learning AI and cloud-based technology.
Aiforia’s solutions strive to increase the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology. Aiforia’s mission is to transform pathology image analysis with AI, enabling better care for each patient.
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications, and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions. Agilent focuses its expertise on six key markets, where we help our customers achieve their goals including Food, Environmental and Forensics, Diagnostics, Pharmaceutical, Chemical and Energy, and Research.
.jpg){kind=logo}
At AGFA HealthCare, we are transforming the delivery of care – supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management.
Focused on our robust and unified Enterprise Imaging Platform, we help our clients manage resource allocation, improve productivity and provide clinical confidence with patient-centric contextual intelligence. The technology speeds diagnoses to drive an improved patient experience. With our core commitment on delivering value, the technology suits multi-specialty requirements and securely standardizes workflows, to collaborate seamlessly between departments and across geographies. From product development to implementation, our best-of-suite Imaging IT software solutions are purpose-built to reduce complexity and support healthcare providers to achieve their clinical, operational and business strategies. AGFA HealthCare is a division of the Agfa-Gevaert Group which is headquartered in Mortsel, Belgium and traded on Euronext Brussels (AGFB).
Accelerated Enrollment Solutions (AES) helps biopharmaceutical companies overcome patient enrollment and research site challenges by combining a powerful patient recruiting solution with more than 160 clinical research sites located throughout the world. As a business of PPD, part of Thermo Fisher Scientific, we are committed to optimizing each step in the patient journey and delivering best-in-class site performance to bring our customers greater certainty to clinical trial delivery.
1st PhileKorea provides products and services related to bio research and diagnosis.
10x Genomics was founded on the vision that this century will bring advances in biomedicine and transform the way we understand and treat disease. We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.
Global Engage is a member of ISLA, a body established to accelerate the event industry transition to a sustainable future. We have reduced waste by replacing printed documentation with an app. Make sure you have it downloaded to your devices in time for the meeting.
You will have some great food choices while you are with us but now we have increased the proportion of plant-based items. We have also built a plan with the venue to avoid waste through how meals are served. Please consider more sustainable alternatives to flying. The app will also have a discussion space to arrange ride shares.
Sponsors and exhibitors at our conferences have the opportunity to meet and form partnerships with delegates on a formal and informal basis in a relaxed and professional atmosphere.
